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Abstract
Bach, Michael T., M.A.

October, 2000

Psychology

The Relationship o f Health Beliefs, Knowledge o f Disease, and Social Support to HealthRelated Quality o f Life in Patients with Inflammatory Bowel Disease
Director: D Balfour Jeffrey, Ph.D.
A great deal o f research has been done to develop treatments that alleviate the physical
symptoms o f inflammatory bowel disease (IBD) In addition, the effects o f
pharmaceutical and surgical interventions on a patient’s health-related quality o f life
(HRQOL) are currently acknowledged as important considerations. Despite this
research, however, and despite interest in the psychological factors that may play an
etiological role in IBD, little research has been done to determine the situational and
personality variables that contribute to HRQOL in IBD.
The primary hypothesis o f this study was that a person’s disease activity, health beliefs,
knowledge about IBD, and satisfaction with social support will account for more o f the
variance in HRQOL scores than will disease activity alone. To test this hypothesis,
subjects with IBD were recruited from doctors’ offices, an on-line chat group, and an
IBD newsletter, and they completed several questionnaires that measured the above
constructs. Stepwise multiple regression and correlational methods revealed that,
although disease activity was a significant predictor o f all aspects o f HRQOL, o f the
remaining variables, only satisfaction with social support provided additional predictive
ability. Post-hoc analyses suggest that social support may be a better predictor of
HRQOL in ulcerative colitis patients than in those with Crohn’s disease. Analyses o f the
HRQOL measurement (the IBDQ) suggest that it is a valid and reliable instrument, but
that the four subscales are too highly correlated to be treated as measuring separate
components o f HRQOL.
Future research should continue to refine the IBDQ and to clarify the conceptual
definition o f HRQOL. In addition, the question o f whether ulcerative colitis and Crohn’s
disease patients differ with respect to the role o f social support should be addressed, in
order to help both groups o f patients experience the highest possible degree o f HRQOL.
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The Relationship o f Health Beliefs, Knowledge o f Disease, and Social Support to
Health-Related Quality o f Life in Patients with Inflammatory Bowel Disease
Chapter 1
Introduction
Overview
This study will attempt to clarify how several different factors are related to
health-related quality o f life in patients with inflammatory bowel disease, or IBD First
this disease will be described, and research concerning its pharmaceutical treatment will
be discussed- It will then be argued that symptom description alone, as measured by
current disease activity indices, does not fully capture the patient’s experience; healthrelated quality o f life is also important.
After discussing the definitions o f quality o f life and health-related quality o f life
(HRQOL), literature describing what is known about HRQOL in EBD patients will be
presented. Because current research indicates that disease activity alone does not fully
account for variance in HRQOL scores, the relationship between disease severity and
HRQOL will also be addressed. Based on a literature review, the following additional
factors HRQOL appear worth investigating: health locus o f control; patient knowledge
o f disease; and satisfaction with social support.
To answer the question “How do the above factors relate to health-related quality
o f life in EBD patients?” questionnaires were filled out by subjects seeing
gastroenterologists in Marquette, MI and Missoula, MT. Additional subjects were also
recruited by posting a study announcement on an Internet message board and in an EBD
newsletter. All patients filled out the questionnaires at home, then mailed them to the
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experimenter in Montana. The relationship between the above variables and HRQOL
was determined by calculating several multiple regression equations and correlation
coefficients. In addition, the internal consistency and intercorrelation o f the subscales of
the HRQOL instrument were computed.

A Description o f IBD
Inflammatory bowel disease affects about 400,000 people in the United States
(Mendeloff, 1980) and millions o f people worldwide. Consisting o f two different
illnesses, Crohn’s disease and ulcerative colitis, IBD is a lifelong condition characterized
by periods o f activity and remission that continue throughout a person’s life. Although
its genetic and environmental precursors have been studied, the etiology o f IBD is
presently unknown (Reif, Klein, Lubin, Farbstein, Hallak, & Gilat, 1997). Men and
women are affected roughly equally by IBD, and it is usually diagnosed before they are
30 (Mendeloff, 1980). Although Crohn’s disease and ulcerative colitis share some of the
same symptoms, such as diarrhea and abdominal pain, the two present themselves
differently to both patients and clinicians.
Crohn’s disease can inflame any part o f the alimentary tract, from the mouth to
the anus, although this inflammation occurs primarily in the small and large intestines
(Whitehead, 1980). During an exacerbation, its sufferers can experience severe
abdominal pain, weight loss, fatigue, and diarrhea (Myren, Bouchier, Watkinson, Softley,
Clamp, & deDombal, 1984), as well as joint pain and complications in the perianal area
(Kombluth, Salomon, & Sachar, 1993). Examination often reveals scar tissue, which
may narrow the intestines in different areas. The inflammation caused by Crohn’s
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disease is typically deeper than the first layer, or mucosa, of the intestines, and can lead
to fistulae, abnormal passages between internal organs (Kombluth, Salomon, & Sachar,
1993). There is currently no cure for Crohn’s disease and, although surgery can be used
to remove inflamed sections o f intestine, the condition usually returns, bringing
continued symptoms (Farmer, Easley, & Farmer, 1992).
The inflammation involved in ulcerative colitis, by contrast, is limited to the large
intestine, and typically involves the rectum (Morson, 1980). The disease is marked by
frequent and bloody diarrhea, which may lead to anemia (Myren et al., 1984, Jewell,
1993). Other symptoms during an exacerbation include abdominal pain, fever, nausea,
weight loss, joint pain and eye irritation (Jewell, 1993). The damage done to the large
intestine is usually limited to the mucosa (Morson, 1980). Currently, the only cure for
the disease is removal o f the colon (Morson, 1980), which occurs in about 30% o f
patients.
Despite the differences in the severity and location o f inflammation in Crohn’s
disease and ulcerative colitis, the two have many similarities and are categorized under
the common heading o f IBD. As mentioned above, both diseases are caused by unknown
factors, and have a clinical course o f exacerbation and remission. Although they are
reliably distinguished from each other today (Myren et al., 1984), the similar symptoms
made the two easily confused by physicians until about 40 years ago, when examination
o f the colon became more common (Taylor, 1980).
The exact medication used depends on the severity o f the disease and the response
o f the individual, however, both diseases are treated with similar drugs (Jewell, 1993;
Kombluth, Salomon, & Sachar, 1993). Although symptoms can be severe during relapse.
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most patients experience periods o f remission during which they are able to perform daily
activities without significant interference (Drossman, Lesserman, Mitchell, Zhiming,
Zagimi, & Patrick, 1991; Joachim & Milne, 1987). Because o f these similarities, the two
diseases are frequently grouped together in studies (Farmer, Easley, & Farmer, 1992;
Irvine et al., 1994; Martin, Leone, & Naccarato, 1995), and they will also be grouped
together in this study.

A Clarification o f the Purpose o f This Study
Before examining the outcome research o f drug therapy for IBD, it is necessary to
clarify the focus o f the present study. Although psychological factors and their
relationship to disease activity are o f interest, no assumption is made that these factors
contribute to the development or severity o f the disease. Many studies have posited a
link between personality and IBD, going as far as stating that EBD (especially ulcerative
colitis) is caused by certain psychological liabilities.
Aronowitz and Spiro (1988) traced the development o f this interest to a paper by
Murray that appeared in 1930. In this paper, Murray noted that patients with ulcerative
colitis were characterized by a personality style that included fearfiilness, conflict and
dependence. This idea was further refined in 1950 when Franz Alexander, a
psychoanalyst, proposed the specificity hypothesis; certain psychological conflicts (such
as the desire to be independent and the desire to be cared for) lead to specific patterns of
arousal in the autonomic nervous system. This arousal then causes damage to particular
areas o f tissue (the colon in the case o f ulcerative colitis). Many psychodynamic studies
followed, with the general agreement that some event (perhaps a narcissistic wound)
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preceded the exacerbation or occurrence o f symptoms, which served as a substitute for
direct aggression or action (Chessick, 1995). Although researchers have searched for a
personality style common to those with Crohn’s disease, this illness has received less
attention than ulcerative colitis. This is most likely due to the fact that Crohn’s disease
was described at a later time than was ulcerative colitis (North and Alpers, 1994).
Although researchers developed complex psychosomatic theories explaining the
etiology o f IBD (particularly ulcerative colitis), their study methodologies have been
criticized on many grounds, for example, sampling bias, lack of control groups,
unsystematic collection of data in a retrospective manner, and the use of cross-sectional
rather than longitudinal designs (North and Alpers, 1994; Zuckerman and Briones, 1989).
Two recent reviews concluded that there is no “IBD personality” and that patients with
ulcerative colitis do not have a higher than normal rate o f psychiatric diagnosis (North
and Alpers, 1994; Zuckerman and Briones, 1989). Although some studies have found
that Crohn’s patients have more diagnoses o f anxiety and depression than patients with
ulcerative colitis (North and Alpers, 1994; Sheffield and Carney, 1976), it is not clear
whether these symptoms precede the disease or if they are a reaction to it (Addolarato,
Stefanini, Capristo, Caputo, Gasbarrini, and Gasbarrini, 1996). In summary, whether or
not the onset or course o f IBD is influenced by stress or other emotional factors is unclear
at this time. Although these unanswered questions remain, the purpose o f this study is
not to investigate the mental or emotional liabilities o f people with IBD, but rather to
examine the psychological strengths that may assist them in adapting to the illness.
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Research Concerning the Pharmacological Treatment o f IBD
Although patients with both diseases may require surgery, their symptoms are
usually managed with some type o f pharmaceutical therapy (Jewell, 1993; Kombluth,
Salomon, & Sachar, 1993). In a two-year study involving over 400 patients with Crohn’s
disease (Malchow, Ewe, Brandes, Goebell, Ehlms, Sommer, & Jedinsky, 1984), patients
were randomly assigned to six-week treatments of either 6-methylprednisolone alone, 6methylprednisolone combined with sulfasalazine, sulfasalazine alone, or a placebo.
Disease activity was measured with Crohn’s Disease Activity Index (CDAI; Best,
Becktel, Singleton, & Kern, 1976) and the van Hees index (van Hees, van Elteren, van
Lier, & van Tongeren, 1980), which will be discussed below. The disease activity o f
patients who responded to treatment was measured for up to two years. Analysis o f the
treatments revealed that, overall, 6-methylprednisolone was the most effective regimen.
It was also superior at reducing disease activity in previously treated patients and in
subgroups with inflammation in the small intestine only, or in both the small and large
intestines. The combination therapy was most effective for previously untreated patients,
and for those with inflammation in the large intestine only.
Powell-Tuck, Bown, & Lennard-Jones (1978) investigated two types of
corticosteroid treatment for patients with ulcerative colitis. Corticosteroids had been
shown efficacious in this population (Truelove & Witts, 1955), but a comparison o f
single vs. divided dosages had not been made Powell-Tuck et al. randomly assigned 45
patients to one o f two groups. Twenty-three patients received a treatment o f 40 mg. of
prednisolone in the morning, and 22 received the same total amount in four separate
administrations each day. The authors reported no differences among the treatments in
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terms o f disease activity, speed o f response, or side effects, and recommended that
patients be given the more convenient single dosage.
Many other studies have been done to test different drug treatments for IBD (for
example, Archambault, Feagan, Fedorak, Groll, Irvine, Kinnear, Laupacis, McDonald,
Rochon, Saibil, 1991; Truelove & Witt, 1955; Yacyshyn, Bowen-Yacyshyn, Jewell,
Tami, Bennett, Kisner, & Shanahan, 1998). They have typically involved great
methodological rigor, using valid and reliable outcome measures o f disease activity and
placebo control groups. Subjects have been randomly assigned to groups, and both they
and the medical staff were blind to treatment condition. Despite the care put into these
studies, however, criticisms have increased recently regarding the outcome measures
used— measures that ignore HRQOL (Garrett & Drossman, 1990; Martin, Leone, Fries,
& Naccarato, 1995; Talal & Drossman, 1995). These criticisms will be discussed later,
but first several disease activity scales will be described.

A Popular Measure o f Disease Activity— The CDAI
Many researchers have attempted to quantify disease activity so that different
drug treatments o f IBD can be evaluated. The earliest measure o f disease activity in
Crohn’s disease was the Crohn’s Disease Activity Index (CDAI; Best et al., 1976). The
CDAI contains a patient-completed questionnaire that asks about symptoms such as
abdominal pain, feelings o f well-being, and the number o f loose stools per week. The
patient fills out this questionnaire over a one-week period. The physician then adds
information and a score is calculated. The CDAI was designed to be convenient,
sensitive to change, and to correlate with physician assessments o f disease activity.
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Scores o f less than 150 are defined as inactive disease, while scores above 450 indicate
very severe activity.
Gastroenterologists from 13 universities and medical centers designed the CDAI.
Through discussion, they chose 18 factors they thought were important for assessing
disease activity. This list was later reduced to eight, which will be described below.
Data was gathered from 112 outpatients who had previously been diagnosed with
Crohn’s disease and who recorded data on a one-week diary card that was turned in at
each visit (total of 187 visits). About 75% o f the subjects were receiving medical
treatment for their Crohn’s disease.
A multiple regression equation was used to predict the physician assessment. The
categories o f physician assessment o f the patient’s health and the number assigned to
them were: (1) very well; (3) fair to good; (5) poor; or (7) very poor. When patients
returned for a follow-up visit, the physicians also gave a rating o f the patient’s change
since the last visit. These ratings were: much better; slightly better; the same; slightly
worse; or much worse. In addition to these physician ratings, the patient diary cards
containing information about abdominal pain, feelings o f well-being, and the number of
loose stools per week were collected at each visit.
Once all the data were collected, the number o f independent variables was
reduced from 18 to 12 using multiple regression with stepwise deletion. Further deletion
reduced this number to eight. These are, in the order they appear on the final CDAI:
number o f liquid or very soft stools per week; sum o f seven daily abdominal pain ratings;
sum o f seven daily ratings o f general well-being; the presence o f various extraintestinal
symptoms (e.g., arthralgia, mouth lesions, skin rash, etc); whether or not the person was
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taking opiates for diarrhea; the presence or absence o f an abdominal mass; hematocrit
value; and bodyweight.
The authors displayed a figure showing the relationship between the computed
CDAI score and the physician rating o f disease. Although no statistics regarding the
agreement between the two ratings were reported, the authors note that, “increasingly
unfavorable subjective physician’s ratings are associated with tendencies toward
increasingly higher CDAI values, but moderate overlap o f ranges occurs” (p. 442). A
later publication stated that the correlation between the CDAI score and the physician
assessment was .70 (Sandler, Jordan, & Kupper, 1988).
Test-retest data was not reported for the CDAI. Instead, the authors reported
retest data from 13 patients with 18 visits whose therapy was unchanged during the data
collection period. Most o f the physician ratings o f change were “the same.” The
reported pooled standard deviation o f the repeated administration was 45.5 CDAI units.
The authors did not discuss whether they thought this finding provided evidence o f the
CDAI’s reliability. Another study, however, reported a test-retest correlation (eight week
period) o f .66 (Irvine et al., 1994). It should be noted, however, that the disease activity
in Crohn’s disease can change substantially in eight weeks, which may explain the
moderate correlation.
deDombal and Softley ( 1987) also examined the CDAI, and they reported
considerable observer variation in the scores o f various disease activity indices, including
the CDAI They had seven physicians who used the CDAI in daily practice assign CDAI
scores to 10 construed case histories. A figure showing the distribution of CDAI scores
for each case was referred to and, although no statistical procedures were described, the
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10
authors noted “considerable discrepancy” (p. 476). They also observed that much o f this
discrepancy seemed attributable to one or two o f the observers who may have been less
familiar with the CDAI. A table revealed a smaller range o f scores when the more
extreme high and low values were eliminated. Examples o f the means and ranges were;
132, with a range o f 108-162; 261, with a range o f 235-310; 305, with a range o f 280330; and 391, with a range o f 373-472. Again, no statistics were used to describe the
table.
The items that caused the most disagreement concerned what defined a liquid
stool, what factors were considered extraintestinal, the hematocrit value, and the
calculation o f ideal body weight. The authors noted that small discrepancies were
multiplied in the calculation of the final CDAI score. They recommended that the
variables in the CDAI be clarified in order to increase inter-observer reliability.
Finally, Goebell, Wienbeck, Schomerus, & Malchow (1990) analyzed data
concerning the CDAI that were gathered from a large study (described above) of Crohn’s
disease patients (Malchow et al., 1984). In addition to completing the CDAI, three
gastroenterologists who were blind to the CDAI score gave each patient a disease rating
o f 1 (not active), 2 (slight), 3 (moderate), 4 (severe), or 5 (very severe). An inter-rater
reliability coefficient was not reported, but the authors stated that in 78% of the cases all
three physicians gave the same score. A single clinical rating was then calculated from
these ratings. The correlation between the CDAI and the clinical rating in this study was
.88. It should be noted, however, that because o f its subjective nature, the general well
being category o f the CDAI was omitted.
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In conclusion, these results and those o f the above studies suggest that, although
the CDAI has limitations (such as moderate reliability), it is probably as trustworthy as
the rating by a medical expert; that is, it taps into domains that gastroenterologists
consider important when making judgements about their patients’ disease activity. The
difficulty o f finding a “gold standard” for the validation o f disease activity measures,
which is discussed below, has likely contributed to the popularity o f the CDAI in
research (Malchow et al, 1984; Yacyshyn et al, 1998).

Other Disease Activity Measures
Disease activity scales have also been designed for use with ulcerative colitis
patients. Truelove and W itt’s (1955) scale for ulcerative colitis uses objective factors
such as body temperature, resting heart rate and hemoglobin count. Although widely
used, this instrument is not sensitive to small degrees o f change in activity because o f its
categorical classification scale— mild, moderate or severe (Singleton, 1987). In attempts
to improve Truelove and W itt’s scale, a number of new indices for ulcerative colitis have
been created. These include the St. Mark’s index (Powell-Tuck, Bown, & LennardJones, 1978), an instrument designed by Seo, Okada, Yao, Ueki, Arima, & Okumura
(1992), and another measure that is a modification o f Truelove and W itt’s scale (Gomes,
duBoulay, Smith, & Holdstock, 1986). These scales produce numerical severity scores
based on a number o f objective and subjective factors.
Some researchers have criticized the CDAI as unreliable and lacking objectivity
because o f the influence o f subjective— patient-reported— factors on its score (CramaBohbouth, Pena, Biemond, Verspaget, Blok, Arndt, Weterman, Pauwels, & Lamers,
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1989; van Hees, et al., 1980). Efforts to make improvements over the CDAI have
generally consisted o f either simplifying it, or including objective parameters. Harvey
and Bradshaw’s (1980) scale is simpler to administer than the CDAI, but correlates
highly with it. The Dutch (van Hees et al., 1980) and Cape Town indices (Wright,
Marks, & Parfitt, 1985) were created to assess the more objective aspects o f the illness.

The Chapel H ill Index
The Chapel Hill Index (CHI; Sandler et al., 1988) was designed to produce scores
comparable to the CDAI without the need for a physical exam or laboratory work. It was
originally designed for survey research with Crohn’s patients, but has also been used to
assess disease activity in subjects with ulcerative colitis. Because it will be used in this
study, it is described in detail below.
The CHI was designed based on data from a trial o f sulfasalazine as a treatment
for Crohn’s disease (Singleton, Summers, Kern, Becktel, Best, Hansen, & Winship, 1979,
as cited in Sandler et al., 1988). Eight centers gathered data on 1082 visits by 89 patients.
At each visit, information on the variables that make up the CDAI score, as well as a
physician rating of disease activity were recorded. The physician rating was used as the
dependent variable in a regression analysis, and had the following categories: 1 (very
well); 3 (fair to good); 5 (poor); and 7 (very poor).
To reach their goal of developing a self-report survey instrument, the authors did
not use the independent variables from the CDAI that required an examination or
labwork. The remaining variables were liquid stool frequency, well-being, abdominal
pain, use o f opiates for diarrhea, and body weight. Several data sets o f 89 observation
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each were formed by randomly selecting one visit from each o f the 89 patients. The
authors then carried out “informal examinations o f regression results” (p. 454), and
decided to keep only the following independent variables; the number o f liquid stools in a
week, amount o f abdominal pain, and general well-being
One hundred samples o f 89 visits (one randomly chosen visit per subject) were
then generated For each o f the three variables, partial regression coefficients were
calculated for predicting the CDAI score. To facilitate interpretation o f their scale, the
authors multiplied these coefficients by a constant, so that the mean (138.4) and standard
deviation (97.2) o f the scale were comparable to the CDAI.
To test the utility o f the CHI, it and the CDAI were used to calculate activity
scores for each o f the 1082 patient visits. These scores were divided into quartiles, and
the agreement between the quartiles o f each index was quantified. Another 100 random
samples o f 89 visits, one from each patient, were then generated. An activity score was
calculated using each index, and the Pearson correlation coefficients between the CDAI
and the CHI were calculated. The sensitivity o f the CHI was also examined by
determining its and the CDAI’s baseline score as a quartile. The agreement between the
instruments (e.g., higher quartile, same quartile, lower quartile) on subsequent visits was
then examined. The authors found that when each index was used to place patients into a
quartile, the agreement between the two was 64% (Kappa=.517). Agreement within one
quartile was 94% (Kappa=.838), which was reported as very high.
Using all 1082 visits, the correlation between the scores o f the two instruments
was .866 (p<0001). In approximately 61% o f the cases, the CHI and the CDAI were in
agreement (by quartile) about change in disease activity. Agreement within one quartile
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occurred 97% o f the time. The authors acknowledged that, because the CHI was not
validated with an independent sample, their results could be biased. However, they
concluded that the CHI is promising in survey research because o f its simplicity, its high
correlation with the CDAI, and its sensitivity to change.
Drossman et al. (1991) used the CHI to survey 320 patients with ulcerative colitis
and 671 patients who had Crohn’s disease as part o f a study o f HRQOL. In addition,
Irvine, Zhou, & Thompson (1996) used the CHI to quantify disease activity in 45 patients
with ulcerative colitis and 150 who had Crohn’s disease in a validation study o f a
shortened form of a HRQOL instrument. In the CHI, the subject’s responses are
multiplied by three different values (three for the number o f loose stools, ten for
abdominal pain, and eight for general well-being) and then added together, producing
scores that range from 0-650. Scores less than 150 indicate that the disease is in
remission. The CHI has only three questions, and takes less than five minutes for the
patient to complete.

Objective vs. Subjective Measures o f Disease Activity
The above studies reveal a debate concerning the use of objective (observed by
the clinician) or subjective (self-reported) factors to measure disease activity. Objective
measures o f disease activity have at least an intuitive advantage over their subjective
counterparts. For example, a hemoglobin count is more stringently defined than “mild”
vs. “moderate” abdominal pain. Both types o f measurements, however, appear to assess
different, yet equally valid aspects o f disease activity Although knowing the degree of
inflammation in the intestines is important, it does not always correspond with the
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patient’s experience o f pain or discomfort. The presence o f minimal inflammation can
produce severe impairments in functioning and, conversely, people with highly inflamed
intestines may report little discomfort (Goebell et al., 1990; Singleton, 1987; Talal &
Drossman, 1995). In addition, obtaining “objective” measurements like hematocrit value
can lead to disagreement (deDombal and Softley, 1987). The lack o f a gold standard for
disease activity validation has caused some to argue that patient ratings should not be
considered less important in the management o f IBD than the results o f lab tests (Garrett
& Drossman, 1990). Their suggestion is to view both types o f ratings as complementary,
each adding important information for diagnosis, because any particular activity scale
describes only a certain aspect o f the disease.
However, both types o f scales have also been criticized as failing to provide
important information about the patient’s perception o f functioning outside the realm o f
his/her physical symptoms. The awareness that IBD affects more than just a person’s
bathroom habits and that it extends in its impact to the social and emotional domains has
increased (Farmer, Easley, & Farmer, 1992; Guyatt et al., 1989). It has become clear that
the current disease activity scales, while providing valuable data, fail to gather some
important information, because even patients whose IBD is in remission (defined by their
score on an activity scale) may have diminished satisfaction with their functioning (Love,
Irvine, & Fedorak, 1992). This knowledge has paved the way for the formation o f scales
that measure health-related quality o f life
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Quality o f Life and HRQOL: Background and Definitions
At this point it is necessary to discuss some o f the difficulties in defining the
construct o f HRQOL. First, however, the more general concept o f quality o f life (QOL)
will be examined. Musschenga (1997) points out that QOL became an important
consideration in medicine after certain interventions, such as the administration of
antibiotics, were discovered. These treatments led to the prolonging o f life, but
sometimes in a diminished capacity compared to pre-illness ftmctioning. Because
different treatments have differential efficacy and side effects (kidney transplantation vs.
kidney dialysis, for example), other considerations than simply whether the patient would
survive became important. Quality o f life is now considered an important outcome in
medicine, as evidenced by the development o f measuring scales for quality o f life in
illnesses such as cancer, asthma, epilepsy, rheumatoid arthritis, angina, diabetes and
AIDS (Bowling, 1995).
Despite the importance o f knowing how a treatment will affect a person’s life,
there has been great difficulty in formulating a definition o f QOL (Anderson and
Burckhardt, 1999; Farquhar, 1995). Farquhar has suggested that one reason for this lack
o f consensus is that many different disciplines are interested in the construct, each
employing a definition that captures the components most interesting to them. Related to
this reason, different standards o f QOL such as objective (number of hours worked) or
subjective (enjoyment o f activities) are often used across and within disciplines.
Using the term QOL without consistency makes comparing different studies
difficult, and it can be confusing when terms such as functional status are used
interchangeably with QOL. Anderson and Burckhardt (1999) defined functional status as

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

17

“individuals’ abilities to meet their basic needs, fulfill roles and maintain well-being (p.
302),” and they add that, although functional status influences QOL, it does not serve as a
synonym for it.
Based on a literature review, Farquhar (1995) described three types o f QOL
definitions. The first type is the global definition, which includes all possible areas o f a
person’s life, fi-om family to work, health, and emotional life. Also included in this
definition is the concept o f happiness vs. unhappiness. Farquhar provides an example o f
a global definition: “the degree of satisfaction or dissatisfaction felt by people with
various aspects o f their lives (p. 503).” Although all areas o f a person’s life are included
in this definition, it is unclear both how to operationalize it and what areas o f a person’s
life are particularly important.
Component definitions, the second type, include only certain dimensions that are
claimed to be central to QOL, such as freedom o f choice and emotional well-being. An
advantage to this approach is easier operationalization and measurement. A downfall,
however, is that the dimensions are chosen arbitrarily, based on the interests o f the
researchers.
Finally, focused definitions are those that use only one or a few components o f
quality o f life, rather than claiming to measure the entire construct. The most common
example is those addressing the component o f health. Faruhar (1995) suggests that, when
this approach is used, it is least confusing when there is explicit acknowledgement that
only a part o f QOL is being addressed— hence the term HRQOL.
Based on these definitions, it is clear that HRQOL is a focused definition that is
not intended to encompass all aspects o f a person’s experience. Before providing a
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specific definition o f HRQOL, however, it should be noted that this construct has been
criticized. Anderson and Burckhardt (1999) disagree with the assumption, central to
HRQOL, that “people make distinctions between some part o f their life that is influenced
by health, and some parts that are not so influenced (p. 302).” They suggest that, in most
studies, the term is simply composed o f variables related to the disease o f interest (i.e.,
physical symptoms).
Although this criticism may have some validity, it is also clear that an illness will
impact some areas o f a person’s life more than others (e.g., occupational role vs. family
relationships). In addition, because quality o f life includes a potentially infinite number
o f components (Farquhar, 1995), restricting the definition to include only those areas
most affected by the illness (HRQOL) not only allows for more accurate measurement,
but also for the promise o f utility to patients who are choosing between alternative
treatments. These considerations lead to the following definition o f HRQOL: “the
functional effect o f an illness and its treatment on a patient, as perceived by the patient”
(Ferry, 1999, p.S15). Note here that “functional effect” does not mean the same thing as
functional status, but refers to a global effect on a person’s life. Based on this definition,
two points should be noted.
First, HRQOL refers to a person’s subjective experience o f IBD, as opposed to
various laboratory measures that a patient is not directly aware of, such as hemoglobin
count, platelet count, or eiythrocyte sedimentation rate (Guyatt, Mitchell, Irvine, Singer,
Williams, Goodacre, & Tompkins, 1989). Second, the experience o f HRQOL goes
beyond the physical symptoms o f IBD (diarrhea, pain, etc.) to its impact on other areas of
a person’s life (Maunder, Cohen, McLeod, & Greenberg, 1995). A basic premise o f this
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article is that, until recently, HRQOL has largely been ignored in IBD research. Based on
this view o f HRQOL, several instruments designed to measure this construct will be
described. First, however, three types o f HRQOL instruments will be discussed.

Criticisms o f Global and Generic HRQOL Instruments
Health-related quality o f life measurements can be classified as global, generic, or
disease-specific (Irvine, 1997). Irvine states that global assessments may give an overall
description o f a patient’s ftmctioning, but they fail to describe specific areas of
impairment. In addition, these measures often yield only categorical scores, such as
good, fair, or poor. Generic questionnaires, by contrast, produce a quantitative score, and
can be used in a variety o f patient groups.
Irvine (1995), however, criticized generic HRQOL instruments by stating that
these measures are subject to systematic error due to possible differences between the
populations that are sampled. For example, patients with inflammatory bowel disease
tend to be younger and have more mobility than do arthritic patients, and socioeconomic
and marital statuses between them may also differ. Thus, differences in scores between
the two groups may be due to factors other than health status, such as age
In addition, generic instruments can be insensitive to differences within a single
population. Irvine (1997) described a study in which a generic HRQOL questionnaire did
not discriminate between ulcerative colitis patients who had undergone surgery and a
group o f healthy controls (Provenzale, Fhillips-Bute, & Shearin, 1995). As an alternative
to global and generic HRQOL scales, Irvine recommends the use of disease-specific
questionnaires— those designed for use in a particular group o f patients.
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The IBDQ—A Disease-Specific HRQOL Instrument
Recognizing the weaknesses o f global and generic questionnaires, several groups
have developed HRQOL instruments specific to IBD. The widely used Inflammatory
Bowel Disease Questionnaire (IBDQ; Guyatt et al., 1989) was designed to be an outcome
measure in clinical trials. This measurement will be used in this study, and it is described
in detail below.
The first step in the development o f the IBDQ was the formation o f 150 items that
described problems faced by IBD patients (Mitchell et al., 1988). These were generated
through an open-ended questionnaire administered to several doctors and clinicians, and
to 77 patients from outpatient settings. Patients who had proctitis alone, or who had
ileostomies, were excluded from this rating procedure. In their description o f this
process, the authors stated that the items formed five different dimensions: bowel
symptoms, systemic symptoms, functional impairment, social impairment, and
disturbances of emotional function. They did not, however, describe the way that these
dimensions were formed.
The 150 items were then rated by 97 IBD patients (43 with ulcerative colitis and
54 with Crohn’s disease) according to importance (“not very important” to “extremely
important”). This produced a reduced list o f 30 items. After additional feedback from
several clinicians, two more items were added. These 32 questions form the IBDQ,
which can be completed in approximately 20 minutes. Scores for each item range from 1
(worst function) to 7 (best function), for a range o f 32-224, In Crohn’s patients who are
experiencing remission, the average IBDQ score is 169 (Irvine, 1997). A similar score
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(174) has been reported for patients with ulcerative colitis (Han, McCoII, Steen, Barton,
& Welfare, 1998). These compare to a mean score o f 211 for individuals without IBD
(Irvine et al., 1994).
In a separate study, Guyatt and colleagues (1989) tested the validity and reliability
o f the IBDQ. They described four subscales into which the IBDQ was divided, but did
not describe the process used to form these sub scales. The first subscale relates to bowel
disturbances and has ten items. It asks questions such as, “How often in the last two
weeks have you been troubled by cramps in your abdomen?” The second sub scale
inquires about systemic symptoms— physical symptoms not directly related to the
gastrointestinal tract— and contains five questions. An example is, “How much energy
have you had in the last two weeks?” The emotional function sub scale contains 12
questions, such as, “How often during the last two weeks have you felt frustrated,
impatient, or restless?” Finally, the social function sub scale has five questions, such as,
“How often during the last two weeks have you had to cancel a social engagement
because o f your bowel problem?” Considering the above discussion of conceptual
difficulties associated with HRQOL, the IBDQ operationalizes HRQOL by referring to
the physical, emotional, and social effects o f IBD. A possible criticism at this point is a
confounding o f physical symptoms with HRQOL Below, the IBDQ will be compared to
three other instruments designed to measure HRQOL in IBD
Guyatt et al. (1989) then administered the IBDQ to 61 patients with IBD (38 with
ulcerative colitis, 23 with Crohn’s disease) from both inpatient and outpatient settings to
establish an average baseline score. They readministered it to them one month later to
obtain a follow-up score. After the second administration, the subjects were divided into

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

22

two groups based on their self-reported change in disease activity. The 19 patients who
reported no change in disease activity were referred to as the stable group. The unstable
group was composed o f thirty-three patients who reported improvement, and nine who
said that they had deteriorated. To determine the IBDQ’s reliability, the scores of the 19
stable patients (whose disease activity had not changed) were examined.
Guyatt et al. (1989) did not report a test-retest correlation for the scores o f the 19
stable patients. Instead, they calculated the average differences between baseline and
follow-up for each subscale. They then calculated the standard deviations o f these
differences. The standard deviation for each subscale was then divided by that subscale’s
average score (baseline plus follow-up divided by two), which yielded a coefficient of
variation for each sub scale. These coefficients were: bowel symptoms, .07; systemic
symptoms, .15; emotional function, .11; and social function, .06. No coefficient was
reported for the IBDQ total score. The authors claim that, compared to other
questionnaires, these are relatively small coefficients (Guyatt, Thompson, & Berman,
1985, as cited in Guyatt et a i, 1989) and conclude that the IBDQ is a reliable instrument.
The IBDQ’s responsiveness (sensitivity to change) was tested by comparing the
average difference score (baseline minus follow-up) for each subscale in the unstable
group to the average difference score in the stable group. The average difference score
for each subscale in the unstable group was divided by the standard deviation o f the
difference scores o f the corresponding subscale in the stable group. For example, the
average difference score o f the bowel subscale in the unstable group was 11.1 points and
the standard deviation o f the bowel subscale in the stable group was 3.7. The resulting
ratio, (11.1/3.7=3.0) is a z-score. The authors explained that, because the number of
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subjects (nine) whose disease activity had deteriorated was too small for a separate
analysis, the sign o f their difference scores (baseline minus follow-up) was reversed.
Their scores were then included with the 33 patients whose scores had increased, for the
analysis just described.
The ratios for the other scales were: systemic symptoms, 1.8; emotional function,
1.4; and social function, 1.7. The authors claim that, since this ratio is greater than 1.0,
the IBDQ is a responsive measure. Guyatt et al. (1989) note, however, that the IBDQ
was more responsive to changes in HRQOL in ulcerative colitis patients than it was in
Crohn’s disease patients. The responsiveness o f the IBDQ in Crohn’s patients will be
discussed below.
Guyatt et al. (1989) also reported on the IBDQ’s validity. Convergent evidence
(Messick, 1980) for its validity was looked for in the 42 subjects with changes in the selfreported global rating of disease activity. Some o f the notable results follow. The
correlation between the patient’s global rating of change in tiredness and change in the
systemic subscale was .36 (p< 05). The correlation between the patient’s global rating of
change in emotional function and change in the emotional subscale was .52 (p<.05). The
correlation between the change in the emotional function sub scale o f the Rand
questionnaire (a generic measure o f physical and emotional functioning; Ware, Brook, &
Davies-Avery, 1980) and change in the emotional subscale was .76, (p< G5). Finally, the
patients’ global rating o f change in disease activity related moderately well with the
changes in the bowel subscale o f the IBDQ (.42, p<.05). No correlations concerning the
IBDQ’s social functioning scale were reported.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

24

As mentioned above, the IBDQ was not as responsive to changes in HRQOL in
Crohn’s disease patients as it was in ulcerative colitis patients. To assess this aspect of
the IBDQ in the former group in greater detail, Irvine et al. (1994) described data from a
study o f 305 Crohn’s patients at 11 different hospitals (Archambault et al., 1991). These
patients were randomly assigned to a group receiving either low-dose cyclosporin or a
placebo. Subjects were administered the IBDQ and two measures o f disease activity—
the Crohn’s Disease Activity Index (CDAI; Best et al., 1976), and the Harvey-Bradshaw
index (HB; Harvey & Bradshaw, 1980)— at two-month intervals for eighteen months. In
addition, subjects and physicians made global assessments o f changes in patient bowel
function, emotional function, and tiredness at each visit. These assessments were made
on a one (a great deal worse) to seven (a great deal better) scale.
To assess responsiveness, Irvine et al. (1994) divided the patients into two groups;
those who experienced a relapse in disease activity during the trial (171 patients), and
those who remained stable (134 subjects). Relapse was defined as an increase of 100
points in the CDAI and a change in steroid therapy. Two measurements, the baseline
score and the lowest score obtained in the trial, were then compared.
The authors reported that the patients who relapsed had low scores (lowest
obtained in the trial) that differed significantly from patients who had stable disease
activity; that is, the IBDQ total score decreased more in patients whose disease activity
worsened than in stable patients. This fact gives evidence for the IBDQ’s responsiveness
in Crohn’s patients. In addition, the bowel and systemic subscales were more responsive
than the emotional and social subscales, causing the authors to suggest that the latter
scales measure something different than the first two scales.
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The authors stated that there is not a gold standard o f HRQOL against which they
could compare the IBDQ. In lieu o f such a standard, they predicted that the disease
activity measures would correlate more highly with the bowel subscale than with the
social and emotional function subscales; no prediction was made concerning the systemic
subscale. Correlations were reported between the IBDQ and the activity indices at the
time o f initial measurement (all were significant). The correlation between the IBDQ
overall score and the CDAI was -.67; thus a higher HRQOL score was associated with
lower disease activity. As predicted, the emotional and social function subscales had
lower correlations (-.50 and -.56, respectively) with the CDAI than did the bowel
sub scale (r= - .71). The same pattern was observed between HB scores and the IBDQ
total and dimensional scores. The authors did not state why predictions were not made
concerning the systemic subscale.
Reliability data in this study were reported in terms o f intraclass correlation
coefficients between IBDQ baseline scores and scores at week 8. The correlations were
as follows; IBDQ total score, .70; bowel subscale, .65; emotional subscale, .65; systemic
subscale, .65; and social subscale, .67. These coefficients were calculated from subjects
with both stable and unstable disease activity, and were much higher than the patient and
physician global reports (.09 and -.05, respectively). The authors conclude that the IBDQ
is a valid and reliable measure of HRQOL.
A more recent study of the psychometric properties o f the IBDQ was conducted
by Han, McColl, Steen, Barton, and Welfare (1998). They randomly selected 38 patients
with ulcerative colitis from a hospital outpatient database, o f which 28 (74%) completed
the study. The subjects were administered the IBDQ three times in a one-month time
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period (each completion was separated by two weeks). On the first and third
assessments, the IBDQ was given in an interview. The second administration was self
completed. The average age o f the patients was 54 years, and all but two had ulcerative
colitis that was in remission.
The average IBDQ score was 174, indicating that this group had relatively high
HRQOL (Irvine et al., 1994). There were no score differences between subjects who
were above the average age with compared those below it on any o f the IBDQ subscale
scores. The average item-total correlation for the IBDQ was .67. The Cronbach’s alphas
for the subscales were as follows: bowel, .81; systemic, .72; emotional, .89; social, .89
An alpha coefficient was not reported for the IBDQ total score. The authors reported that
the internal consistency for the subscales was similar whether the IBDQ was intervieweror self-administered.
Intra-class correlation coefficients between the three administration times were
also calculated to assess the test-retest reliability o f each subscale. Correlations between
the interviewer- and self-administered scores ranged from .73 to .93. Correlations
between the two interview-obtained periods were slightly lower, with intra-class
correlations ranging from .62 to .79. The lower correlations between the interviews may
reflect actual changes in HRQOL, however, as they occurred one month apart from each
other. Across all three administrations, the test-retest correlations were: bowel, .79;
systemic, .71; emotional, .79; and social, .88.
To summarize, the IBDQ subscales have high internal consistency and test-retest
stability. The test-retest correlation o f the IBDQ total score is also high, but its internal
consistency has not been reported. Although validity research is limited, the subscales
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are related to disease activity and to other self-reported measurements in a theoretically
consistent fashion. The IBDQ is convenient for research use, requiring a subject
approximately 20 minutes to complete.

Other Health-Related Quality o f Life Scales
Other groups have designed HRQOL instruments for IBD patients. Before
describing them, however, it should be noted that they differ from the IBDQ in different
respects, an example o f the intra-disciplinary variance in conceptual definition that was
noted above (Farquhar, 1995). Despite these differences, however, an important
similarity remains: an interest in the effects o f IBD on various aspects o f the lives o f the
patient, as rated by the patient.
The first group. Farmer, Easley, and Farmer (1992), designed their questionnaire
to assist physicians in their management of IBD symptoms. Four areas of daily living are
investigated with this measure. The Functional/Economic category assesses the ability to
function at work, school and home. Satisfaction with personal relationships and
recreational activities is measured by the Social/Recreational subscale. Attitude (positive
or negative) toward the future and life in general is measured by the category called
Affect/Life in General. Finally, Medical/Symptoms relates to physical symptoms and
health-related behaviors. The way in which these subscales were formed was not
described. This scale is similar to the IBDQ in its inclusion o f scales addressing physical
symptoms and emotional and social functioning, but it also includes attitude toward the
future. In addition the patient’s ability to function is addressed, leaving this questionnaire
open to the criticism— discussed above— o f confounding HRQOL and functional status.
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The instrument has 18 questions, and takes 15-20 minutes to administer. Each question is
rated from one to five for a maximum score o f ninety, with higher scores representing
better functioning.
To choose the items o f this instrument, the authors administered a 47-question
interview to 70 outpatients with Crohn’s disease and 94 who had ulcerative colitis. These
patients were classified into two groups, surgical and nonsurgical, for a total o f four
patient groups. A two way (Surgery by Disease Type) ANOVA was conducted on the
total scores o f each patient group. F-tests o f significant (p< 01), or what were referred to
as marginally significant values (p=.01 to .05), were reached for 18 o f the 45 questions,
which were used for the final version o f this instrument.
The authors assessed reliability by readministering the 45 questions to 23 patients,
two weeks after the initial interview, and they reported that the Spearman correlation
coefficients were between .75 and .95, The correlations for the final 18 questions,
however, were not reported. The authors stated that patients with Crohn’s disease had
impaired HRQOL compared to patients with ulcerative colitis. Having surgery was also
related to a poorer score, and those who had surgery and Crohn’s disease had the worst
scores o f all. No other data concerning validity was given.
Martin, Leone, Fries and Naccarato (1995) developed a HRQOL scale similar to
the IBDQ for use in the physician management o f IBD, as well as an outcome measure in
clinical trials. Like the IBDQ it has four scales (intestinal, systemic, emotional, and
social), and like the IBDQ it can be criticized for confusing HRQOL with physical
symptoms. Martin et al ’s instrument consists o f 29 questions, each o f which is rated
from 0 (never or hardly ever) to 3 (always or nearly always). Scores range from 0-87,
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with higher scores indicating worse functioning. Patients can complete the questionnaire
in about 10 minutes.
To determine the questionnaire’s reliability, 23 patients with IBD were given the
test twice in a two-week period. The average scores and standard deviations for the two
administrations were 19.6 ±13.6 and 16.8+12.6. The authors stated that that the variation
(15%) was not significant, but did not report the statistical test used to ascertain this. The
validity o f the questionnaire was determined by giving it to 72 healthy controls and to
112 patients (57 with ulcerative colitis and 55 with Crohn’s disease). The Crohn’s
Disease Activity Index (Best, et al , 1976) and Truelove and W itt’s (1955) index were
used to classify the patient’s disease as in remission, mild, or moderate/severe. The
authors reported that patients with ulcerative colitis in remission had significantly higher
scores (diminished function) than the controls. Similarly, patients with mild disease
activity scored significantly higher than those who were in remission. Those with
moderate/severe disease activity scored higher than those with mild disease. The same
pattern was obtained for patients with Crohn’s disease. Again, the authors did not report
the statistical test that was used.
Finally, Drossman, Lesserman, Li, Mitchell, Zagami, and Patrick (1991) have
developed the Rating Form of IBD Patient Concerns (RFIPC). It is a 25-item, self
administered questionnaire that contains concerns expressed by IBD patients that were
gathered through both informal and semi-structured interviews. The RFIPC asks
questions such as, “How concerned are you with the effects o f your medication?”
Patients respond to the questions using a visual analog scale that ranges from 0 (not at all
concerned) to 100 (very concerned). In addition to scores for individual items, an
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average score for ail items (Sumscore) is calculated. This instrument appears especially
susceptible to the criticism that it merely measures an emotional component of HRQOL,
namely, worries or concerns. It differs from the HRQOL scales described above by not
including separate scales that purport to address different aspects o f HRQOL.
The RFIPC was administered to 62 IBD patients, and had a test-retest correlation
o f .87 for the Sumscore and an average correlation o f .65 for the individual items. It was
then administered to over 900 IBD patients (320 with ulcerative colitis, 671 with Crohn’s
disease). A factor analysis on the 25 items yielded four factors with Eigen values greater
than 1.0; impact of disease; sexual intimacy; complications o f disease; and body stigma.
The Cronbach’s alpha coefficients for these four indices ranged from .79- 91.
Evidence for the RFIPC’s construct validity was found in the differences in
concerns between Crohn’s and ulcerative colitis patients. Those with Crohn’s disease
worried more about pain and suffering, energy level, and being a burden on others.
Ulcerative colitis patients, however, reported more concerns related to developing cancer,
Drossman et al. (1991) note that these concerns relate to clinical differences between the
two diseases in symptom intensity and risk of cancer.
O f the above HRQOL scales, the most work has been done concerning the
IBDQ’s validity. In addition, researchers have been more concerned with showing the
reliability o f the IBDQ, which may be due to the IBDQ’s introduction as an outcome
measure in clinical trials. Despite the popularity o f the IBDQ, however, several different
scales have been designed to measure an important component to the experience of
IBD— health-related quality o f life. It is not clear, however, that they are all measuring
the same construct. Although the IBDQ and scales designed by Farmer, Easley, and
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Farmer (1992) and Martin et al. (1995) have similar scales, they are not identical. In
addition, the RFIPC (Drossman et al., 1991) appears to focus on the emotional impact of
IBD. Thus, similar to the disease activity scales, no “gold standard” exists for HRQOL in
IBD. However, the extensive work and favorable results on the IBDQ make it the best
candidate for exploratory work for factors that are related to HRQOL in this area of
study.

Research Concerning HRQOL in IBD Patients
Early studies o f HRQOL in IBD patients examined how the disease affected
various aspects o f their lives. Joachim and Milne (1987) questioned 80 people with IBD
and observed that they reported a number o f illness-related perceptions that often go
unnoticed by physicians. Forty percent o f their subjects reported that having IBD
lessened their overall satisfaction with life, and contentment in areas such as
relationships, recreation, and sexuality was diminished. Although this study lacked a
control group, it demonstrated that the impact o f IBD extends beyond its physical
symptoms.
Drossman, Patrick, Mitchell, Zagami, and Appelbaum (1989) investigated the
relationship between disease activity, HRQOL, and utilization o f health care. Compared
to a control group, IBD patients had more trouble in the areas o f work, recreation, social
interaction, emotional behavior, and sleep and rest. Patients suffering from Crohn’s
disease reported more overall maladjustment than patients who had ulcerative colitis. A
patient’s HRQOL score predicted the use o f health services better than did a physician
rating o f disease activity, which shows the impact this construct may have on behavior.
The authors also reported that IBD patients have a number o f worries, such as needing an
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ostomy bag or surgery and developing cancer, concerns that traditional disease measures
ignore.
Drossman et al. (1991) surveyed nearly 1,000 people with IBD. Compared to a
control group, these patients had more dysfunction in the areas o f social contact,
recreation, sleep and rest, and daily work. Again, patients with Crohn’s disease
experienced more impairment, which the authors explained by their more severe disease
activity. The authors also suggested that knowing a patient’s degree o f psychological
distress and well-being are valuable for predicting both physician visits and
hospitalization.
In what they referred to as the first quantitative study o f its kind, Mitchell, Guyatt,
Singer, Irvine, Goodacre, Tompkins, Williams, and Wagner (1988) attempted to ascertain
the impact o f IBD on a number o f life functions. Their subjects reported the most
problems with areas such as fatigue, feeling run down, and the emotions o f frustration
and depression. The subjects did not report many problems relating to social and
functional impairment. However, many subjects expressed a fear of possible surgery.
The authors recommend monitoring more than just physical symptoms in clinical trials.
In summary, although IBD impacts a person’s physical health, it also adversely affects
his or her emotional and social functioning.

The Use o f HRQOL Instruments as Outcome Measures in Clinical Trials
As mentioned above, health-related quality o f life measures have not always been
a part o f evaluating interventions for IBD, evidenced by a review o f surgical trials which
revealed that only three o f ninety-nine discussed HRQOL (O’Young & McPeek, 1986).
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However, researchers have begun to include these instruments in studies that evaluate
different surgical and therapeutic interventions. In their review article. Maunder, Cohen,
McLeod, & Greenberg (1995) evaluated the effects o f surgery, drugs, and home
parenteral nutrition on HRQOL. They categorized these studies according to their
methodology and the quality o f the HRQOL measure used. Instruments such as the
IBDQ and the RFIPC were considered more useful than those that had not demonstrated
validity or reliability.
The authors found that the use o f measures like the IBDQ and RFIPC has
increased in recent years. Between 1981 and 1987 only two studies used such
instruments, while five articles utilized them between 1988 and 1994. They also reported
that a greater proportion o f the studies in recent years have been prospective and
controlled.
As fiirther examples o f recent interest in HRQOL, two recent drug trials for new
treatments o f Crohn’s disease have used the IBDQ as one o f the outcome measures of
drug efficacy. Yacyshyn et al. (1998) tested the efficacy of ISIS 2302, an antisense
phosphorothioate oligodeoxynucleotide, in 20 patients with active Crohn’s disease and
found that improved disease activity was associated with increased HRQOL. Infliximab,
a chimeric monoclonal antibody, was approved by the FDA in 1998 for the treatment of
steroid-dependent Crohn’s disease. A study examining its effectiveness (Targan,
Hanauer, Van Deventer, Mayer, Present, Braakman, De Woody, Schaible, and Rutgeerts,
1997) used patients’ IBDQ scores as part o f the definition o f a clinical response to the
drug, with findings similar to that o f Yacyshyn et al. (1998). The fact that the trials
testing these new drugs are using the IBDQ gives evidence o f the rising interest in
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HRQOL among those who are studying the treatment o f IBD, and they mirror the great
interest in this subject in medicine in general (Bowling, 1995).

The Relationship Between Disease Activity and HRQOL
If HRQOL scores are too highly related to measures assessing disease activity,
then the usefulness o f this additional construct is doubtful. However, the relation
between the two is not a perfect one. Research that provides insight into this relationship
comes either from controlled drug trials or from investigations o f HRQOL in IBD
patients. The research that follows utilizes reliable, valid measures o f disease activity
Studies that use categorical disease activity scales (e g , good, fair, poor) are not
mentioned here, due to the fact that such measures are relatively insensitive to clinical
change (Irvine, 1995; Singleton, 1987).
Irvine et al. (1994) conducted a multi-center trial (described in detail above)
involving over 300 patients with Crohn’s disease. To summarize, the subscales were
differentially related to disease activity— from a correlation o f -.71 for the bowel subscale
to a correlation of -.50 for the emotional function subscale. A figure depicting the
distribution of IBDQ and CDAI scores revealed that for a given CDAI score, the IBDQ
scores were scattered over roughly 80 points. Irvine et al. conclude that “the IBDQ and
dimensional [subscale] scores are tapping domains distinct from the activity indexes” (p.
292).
Turnbull and Vallis (1995) studied the relationship between disease severity,
psychological factors, and HRQOL in 16 patients with Crohn’s disease and six who had
ulcerative colitis. Disease activity was measured with the Dutch Activity Index (van

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

35

Hees et al., 1980) and the St. Mark’s index (Poweil-Tuck et al., 1978), respectively, and
the IBDQ was used to assess HRQOL. The authors found that disease activity alone was
not significantly correlated with the IBDQ overall score (r= 41). However, when disease
activity was combined with other factors, such as social interaction, recreation, and work
role to form a single composite score, this correlation was significant (r=.53).
Vallis and Turnbull (1996) reported the relationship between disease activity,
measured by the Dutch Activity Index (van Hees et al., 1980), and the IBDQ in 39
Crohn’s patients. When 26 patients were readministered the measurements
approximately four months later, the resulting correlation coefficients were significant
only between disease activity and the IBDQ’s bowel and systemic subscales (r= -.46 and
-.44, respectively).
The weaker correlations reported in the last two studies were probably due to the
disease activity scales that were used. The instruments used by Turnbull and Vallis
(1995, 1996) assessed objective parameters, such as erythrocyte sedimentation rate,
albumin levels, and colonic appearance. The CDAI, by contrast, investigates several
subjective factors, such as a patient’s perception o f abdominal pain and general well
being. Because several o f the IBDQ’s questions are also related to pain and well-being, it
is not surprising that the correlations between its scales and the CDAI were higher.
These studies indicate that HRQOL and disease severity, whether defined in
objective or subjective terms, are related. This finding is intuitive; a very sick person is
less able to enjoy life However, these studies also suggest that factors beyond illness
alone determine the extent to which IBD affects an individual’s satisfaction with life.
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The following sections summarize the theoretical and empirical articles that discuss what
these factors may be.

Theory About Factors that Influence HRQOL in IBD Patients
Garrett and Drossman (1990) drew a distinction between disease and illness,
defining disease as a physical process that does harm to the body and that can be
observed or inferred without asking for the patient’s perceptions (for example, by a blood
test). Illness, however, is the patient’s experience o f disease and includes “how the
symptoms are perceived, evaluated, and acted upon ” (p. 95). For example, someone
might have a normal sigmoidoscopy, yet experience intense abdominal pain. The authors
propose that health status—the interaction o f disease and illness— depends on several
factors; psychological status, coping style, social support, culture, and the presence or
absence o f stressful life events. In their model, disease activity per se is just one
contributing factor to HRQOL.
Talal and Drossman (1995) reviewed research concerned with the relationship
between stress and IBD symptoms. They agreed that, in addition to disease activity, a
person’s response to IBD depends on the factors listed above (psychological status,
coping style, social support, etc.). In addition, they claimed that the relationship between
health status (HRQOL) and the factors contributing to it is bidirectional (e.g., poor health
status may lead to depression, and vice versa). Given these claims, an empirical search
for factors relating to HRQOL has promise for increased understanding and improved
treatment. The following sections review literature investigating the influence o f health
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beliefs, patient knowledge o f the disease, and satisfaction with social support on HRQOL
in IBD patients and in other patient groups.

The Relationship o f Health Locus o f Control to HRQOL in Other Groups
A person who believes that his or her behavior determines health has an internal
health locus of control, whereas someone who attributes health to factors beyond his or
her control has an external health locus o f control. Much research examining the
relationship between health locus o f control and quality o f life has been published with
patients diagnosed with breast cancer (Payne, 1992), osteoarthritis (Laborde and Powers,
1985), systematic lupus erythematosus (Pfieffer and Wetstone, 1988), renal disease
(Bremer, 1995), cardiac illness (Powers, 1994), and chronic pain (Crisson and Keefe,
1988). Comparisons between these studies are difficult, however, because although
many used the same measurement o f health locus o f control (the Multidimensional
Health Locus o f Control Scales; Wallston, Wallston, and De Veil is, 1978), the definition
o f HRQOL has varied greatly and has often been confused with adjustment to disease, as
is the case with the above studies. This makes clear statements about health locus of
control and HRQOL impossible, but the studies are still valuable because they
demonstrate that factors such as health beliefs are related to psychological adjustment.
Because psychological adjustment is often included in the operational definition of
HRQOL, increased adjustment is likely to be associated with more favorable HRQOL.
The above research can be summarized as having mixed results. Although some
studies report a relationship between adjustment and internal health locus o f control—
that is, that an internal health locus o f control predicts better adjustment—other studies
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have not confirmed this finding. In fact, some authors report that an internal locus of
control is related to increased psychological distress (Affleck, Tennen, Pfieffer, & Fifield,
1987).
Andrykowski and Brady (1994) suggest that these inconsistencies are due to the
complex relationship between health beliefs and adjustment to disease. They propose
that two variables may serve as moderators in this relationship; the control realities of the
situation, and the degree o f threat. The control realities o f the situation refer to whether
or not a person actually has some influence over his or her illness. These realities may
cause a person with an internal health locus o f control to experience increased depression
when faced with a terminal illness. In addition, health beliefs become more important to
adjustment when the perceived threat of a disease is great. To summarize, the
relationship between health beliefs and adjustment is complex, and it is not necessarily a
direct one. One would expect to find a similar relationship between health beliefs and
HRQOL

The Relationship o f Health Locus o f Control to HRQOL in IBD Patients
Although the relationship o f health locus of control to HRQOL have been
investigated in many patient groups, no studies have assessed this relationship in IBD
patients. Some authors have, however, examined levels o f locus o f control (a more
general belief in one’s ability to control outcomes in life) in IBD patients. An internal
locus o f control indicates a belief that one’s own actions are instrumental in determining
these outcomes, and an external locus o f control refers to the belief that “fate” or other
people control one’s life. Engstrom (1991) compared the locus of control o f children
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with EBD to children with diabetes and to a control group. He reported that children with
IBD had a more external locus o f control than the other groups, and that increased disease
activity was predictive o f a more external locus o f control (r= 67, p<.01). No relationship
was found between locus o f control and the presence o f a psychiatric disorder (defined by
criteria described in the Diagnostic and Statistical Manual, third edition, revised;
American Psychiatric Association, 1987).
Steinhausen (1982), however, reported that children with IBD have a more
internal locus o f control than do healthy children. He acknowledged that this finding was
contrary to findings in other illnesses, but he did not provide a clear description for the
discrepancy. He also reported no relationship between locus o f control score and severity
o f illness, which may have been due to a relatively small sample size (ten patients with
Crohn’s disease and seven with ulcerative colitis). Subjects with psychiatric disturbance
in this study (defined by the results of an interview) had a more external locus o f control.
The above studies involved children, and did not assess health locus o f control,
however, two other studies have examined coping patterns in adult IBD patients. While
these did not assess health locus of control directly, they provide information about what
kinds o f coping strategies are important to these patients. The relationship o f these
strategies to health locus o f control will be discussed below. In the first study, Kinash,
Fischer, Lukie, and Carr (1993) gathered information about coping style, personality
characteristics, severity o f depression, and disease activity from 88 patients with Crohn’s
disease and 62 diagnosed with ulcerative colitis. Coping style was measured with the
Jalowiec Coping Scale (Jalowiec, Murphy, & Powers, 1984).
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Kinash et al. (1993) reported that individuals in both patient groups had similar
coping patterns, regardless o f their disease severity or the amount o f depression they were
experiencing. The three most commonly used coping strategies for coping with EBD
were: (1) trying to maintain control over the situation, (2) trying to see all aspects of their
situation, and (3) gathering more information about their situation. Examples of
uncommonly used strategies were letting someone else handle the situation, and blaming
someone else for the problem, evidence against the notion that IBD patients have a
passive and dependent personality style.
Satisfaction with life in general was negatively related (r= -.32, p< 05) to the use
o f coping methods designed to manage the distressing emotions caused by IBD
(affective-oriented coping), such as using relaxation techniques to deal with anxiety. The
use o f strategies for changing one’s situation (problem-oriented coping; e.g., getting more
information about EBD) was positively related to life satisfaction (r=.07), although this
relationship was nonsignificant. The way in which life satisfaction was defined,
however, was not specified. Similarly, those who engaged in affective- vs. problemoriented coping strategies reported greater deterioration in relationship satisfaction with
family and friends but, again, the way that this satisfaction was ascertained was not
described.
In summary, the group o f patients in this study appeared to benefit the most from
coping methods aimed at changing one’s circumstances, behavior that may originate from
a belief that their own actions largely determine their health (an internal locus o f control).
This interpretation is supported by Steinhausen’s (1982) findings that children with IBD
have a more internal locus o f control than do healthy children.
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Aware of these findings, Smolen and Topp (1998) predicted that IBD patients
would prefer problem-focused forms o f copings, those aimed at actively improving their
situation, and that they would find these methods effective. These coping styles were
contrasted to emotion-focused coping techniques, which are attempts to deal with the
distressing emotions that a situation evokes. They also predicted that as problem-focused
coping strategies increased, the patient’s well-being would increase. The authors
investigated these predictions by administering questionnaires to 33 patients with Crohn’s
disease and 13 who had ulcerative colitis, and they used the Jalowiec Coping Scale to
assess the occurrence and usefulness o f coping strategies. Well-being was measured by
three subscales (mental health, pain, and energy/vitality) o f the Health Status
Questionnaire (McHomey, Ware, Lu, & Sherboume, 1994).
The authors reported that one of the two problem-focused strategies (Supportant,
which involves making use o f supportive resources) was rated the most effective by the
subjects. The other problem focused method, Confrontive, which involves facing the
situation, was the third most effective strategy. A finding not in accord with their
predictions was that Optimism, an emotion-focused coping style characterized by a
positive outlook toward the situation, was rated the second most effective strategy. When
the self-reported effectiveness o f Optimism was entered into a regression equation, it
accounted for 39% of the variance in rated well-being Another finding that did not
support the authors’ predictions was that the use o f neither Confrontive nor Supportive
coping methods was related to well-being (r= -.04 and -.24, respectively). The authors
did not explain why these correlations were not in the predicted direction. They did point
out, however, that the use o f emotion-focused coping strategies such as avoiding the
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problem, feeling hopeless, and responding emotionally to the problem were significantly
related to decreased well-being. These studies suggest that many IBD patients use active
coping strategies to deal with their illness, and that certain forms o f coping strategies—
those which do not attempt to change the situation— are related to lower levels o f well
being. It is not clear why Confrontive and Supportive coping methods were unrelated to
well-being. It is possible, however, that this was due to the definition of well-being that
was used— one derived from a HRQOL measure that is not disease-specific.
Although the above studies do not directly address the relationship between health
locus o f control and HRQOL in IBD patients, they provide good reason for studying this
relationship using a disease-specific measure o f HRQOL. The fact that IBD patients use
coping techniques aimed at changing their situation (e.g., gathering more information)
indicates that they believe something can be done to change their situation. That is, their
appraisal o f the situation (something can be done to reduce the environmental stressor)
may have influenced the coping technique chosen (Lazarus, 1992). Whether or not
health locus o f control is related to this appraisal is a part o f the present study’s
investigation.

Measurement o f Health Locus o f Control
In the present study, health locus of control was measured by Form C o f the
Multidimensional Health Locus o f Control Scales (MHLC-C; Wallston, Stein, & Smith,
1994), an 18-item questionnaire that is a variation of an earlier instrument measuring a
person’s beliefs about his or health. The reliability and validity of the original instrument
(Forms A and B) were described by Wallston, Wallston, & DeVellis (1978). Wallston et
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al. (1994) divided their modified instrument (by the process described below) into four
belief dimensions.
The first dimension, labeled Internal, assesses the degree to which a person
believes that his or her own actions determine health. The Chance scale determines
whether a person believes that fate or luck primarily determines health, and beliefs
regarding the control o f doctors over one’s health are measured by the Doctors scale.
Finally, the Other People scale asks about the perceived influence o f non-health
professionals on the health of the an individual. The first two scales contain six questions
each, and the latter each contain three. Each item is rated on a six point Likert-type scale
ranging from one (strongly disagree) to six (strongly agree). The MHLC-C was designed
to yield four separate scores, as opposed to one total value, and the entire instrument can
be completed in five to ten minutes.
The questions for Form C were written to apply to any particular illness, as
opposed to health in general. Wallston et al. (1994) claimed that by assessing more
specific beliefs about an illness, predictions about future behavior are more accurate.
They also stated that a person’s beliefs about health in general may differ from those
related to a specific condition. Finally, they observed that persons with specific health
conditions may be unsure whether to answer a question such as, “If I do the right things I
can stay healthy” as it relates to their overall health status or to their specific disease.
They reasoned that a parallel question focused more on the person’s disease such as, “If I
take the right actions, my condition should improve ” would be less ambiguous and assess
more specific health beliefs.
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With these observations in mind, Wallston and colleagues (1994) wrote 24
questions, developed on the basis o f their face validity, that would be comparable to the
original version o f the MHLC Scale (Wallston et al., 1978). These items used the word
“condition” instead o f “health,” and fell into categories o f Internal, Chance, and Powerful
Others. To ascertain the reliability and validity o f Form C, studies were conducted with
patients o f five different groups: rheumatoid arthritis, chronic pain (location unspecified),
diabetes (Type I and Type II), and two cancer groups (type unspecified). All subjects
completed the 24-item Form C, as well as another measure o f health locus o f control, and
measures o f pain, helplessness, and depression.
Before carrying out item and factor analyses for Form C, data from all five patient
groups were combined, then the subjects were then randomly divided into two groups for
cross-validation purposes (Sample 1: n=596 subjects. Sample 2: n=580 subjects). The
factor analysis that was carried out on the data from Sample 1 yielded four factors:
Intemality (eight items). Chance (eight items). Doctors (four items), and Powerful Others
(four items). To make Form C comparable to the original, 18-question MHLC, the
number o f items in each factor was reduced to six, six, three, and three, respectively, by
eliminating the items with the weakest loadings. Wallston et al. (1994) reported
reliability coefficients for the respective scales o f .85, .79, .71, and .70 in Sample 2. In
addition, the test-retest stability o f Form C was examined in the group of chronic pain
study. The corresponding correlation coefficients for the Internal, Chance, Doctors, and
Powerful Others scales were .80, .72, .58, and .40, respectively (one month interval).
The validity o f Form C was assessed in several ways. In the first, the group of
chronic pain patients received an intervention designed to change health locus of control
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beliefs (mainly by weakening beliefs in pain helplessness). After this intervention, the
Internal scale was significantly higher, and the Chance, Doctors, and Other People scales
decreased significantly. The authors reported this as evidence o f Form C’s construct
validity.
Concurrent validity was investigated by comparing Form C with one o f the
original MHLC Scales (Form B). The correlation between the Internal scales of Form C
and Form B was .59 (p<.001), and the corresponding correlation between the two Forms’
Chance scales was .65 (p<.001). Finally, the Doctors and Powerful Others scales of
Form C were significantly correlated with the Powerful Others scale o f Form B (r=.55
and .38, respectively).
Intercorrelations between the scales o f Form C in Sample 2 were also reported,
and they tended to be related in a theoretically consistent way. For example, the Internal
and Chance scales were inversely related (r= -.19, p<.05), but the Doctors and Other
People scales were positively correlated (r=.22, p<.05). In summary. Form C has four
separate scales that have high internal consistency and moderate relationships to each
other. These scales responded in a theoretically consistent way to an intervention
designed to change health beliefs, and they are related to an earlier version of the MHLC
Scales. In addition, the test-retest coefficients are higher for the Internal and Chance
scales (.80 and .72, respectively) than for the Doctors and Powerful Others scales (.58
and .40, respectively), which supports the use o f the Internal scale in this study.
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The Relationship o f Patient Knowledge o f Disease to HRQOL in Other Groups
Having knowledge about one’s medical condition seems intuitively related to a
person’s adaptation to illness. The importance o f such knowledge has been studied in
conditions such as chronic pain (LeFort, Gray-Donald, Rowat, & Jeans, 1998), cancer
(Ferrell, Ferrell, Ahn, & Tran, 1994; Taplin, Blanke, & Baughman, 1997), congestive
heart failure (Frattini, Lindsay, Kerr, & Park, 1998), and diabetes (Glasgow, 1995). As
will be shown below, HRQOL is one area impacted by increased patient knowledge.
LeFort et al. (1998) studied the effects o f a psychoeducational program on pain,
depression, perceived level o f disability, self-efficacy, and HRQOL in a population of
chronic pain patients. These subjects were randomly assigned to either the program
(n=57) or to a control group (n=53). The program topics included education about the
physiology o f chronic pain, nutrition, coping strategies, and exercise. This intervention
lasted for two hours per session and continued for six weeks. The Medical Outcomes
Study Short Form-36 (SF-36; Ware & Sherboume, 1992) was used to assess HRQOL.
This scale is a generic quality o f life scale that assesses areas including physical function,
social function, and general mental health.
The authors reported the effects o f the psychoeducational program on a number of
outcomes, however, its effect on HRQOL will be discussed here. The Physical role.
Bodily pain, and Vitality subscales o f the SF-36 changed significantly after treatment. In
addition, although the mental health and social function scales did not differ significantly
from pre- to post-test, they changed in the same direction. As discussed above, a diseasespecific HRQOL instrument might have been more responsive to patient education
(Irvine, 1997). The authors concluded that similar programs for increasing patient
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knowledge provide promise for increasing HRQOL in chronic pain patients and that they
deserve further research.

The Relationship o f Patient Knowledge o f Disease to HRQOL in IBD Patients
This finding suggests that increasing a patient’s information about IBD can also
raise his or her HRQOL. Although this relationship has not been well-studied in IBD
patients, some research has been reported. Moser et al. (1995) assessed HRQOL using
the Rating Patient Form o f IBD Concerns (RFIPC; Drossman et al., 1991) in 72 patients
with Crohn’s disease and 33 ulcerative colitis patients. Disease activity was classified as
severe/moderate or moderate using the CD AI (Best et al., 1976) and the Colitis Activity
Index (Rachmilewitz, 1989), and patient knowledge was measured by a visual analog
scale (0, totally uninformed to 100, very well informed) that subjects used to estimate
their knowledge about IBD
The authors reported that the correlation between disease activity and HRQOL
was not significant. They did, however, find a significant correlation between the
Sumscore o f the RFIPC and estimated disease knowledge (r=-.20). Thus as knowledge
about IBD increased, worries about the illness decreased. A weakness o f this study is the
lack o f an objective measure o f patient knowledge, however, the results suggest that more
knowledge o f IBD increases adjustment to it.
Smart, Mayberry, Calcraft, Morris, & Rhodes (1986) gave 175 patients with
Crohn’s disease an information booklet on topics such as the symptoms, etiology and
treatment o f their illness. One year later, the 125 who could be reached and who had read
the booklet were asked for their impressions o f it. Eighty-two percent reported that the
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information was valuable, and nearly as many said that they had learned more about
Crohn’s disease from reading it. When asked about the effects o f this material on anxiety
levels, 30% said it had decreased, 13% reported an increase, and 57% reported no
change. Smart et al.’s (1986) study reproduces the finding that while the majority of
patients desire more information, about 20-30% do not desire more information because
they find it threatening (Jones, Gallacher, Lobo, & Axon, 1993; Mansfield, Tanner, &
Branble, 1997). This majority who desire more information may find this to be an
effective coping style (Kinash et al., 1993). Patients who wish to know more about their
illness typically ask about topics such as causal factors, new treatments, and risks in areas
such as conception, pregnancy or cancer (Martin, Leone, Castagliuolo, Mario, &
Naccarato, 1992).

M easurement o f Patient Knowledge
In this study, a patient’s knowledge about IBD was measured using the
Knowledge Questionnaire (KQ), a patient-completed form consisting of 37 true or false
questions (Jones et al., 1993). The KQ was designed for both Crohn’s and ulcerative
colitis patients, and can be completed in approximately 15 minutes. The topics o f the test
include the anatomy and function o f the gastrointestinal tract, extraintestinal symptoms of
the disease, medical and surgical treatments, and how patients can manage their disease.
A 44-question test was initially developed from a study that involved 64 patients
with Crohn’s disease (Rees, Mayberry, & Calcraft, 1983) who listed topics that they
desired more information about. The 44 questions, however, contained questions
relevant to both Crohn’s disease and ulcerative colitis. This instrument was then given to
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20 consecutive patients (type o f disease was not specified) at a colitis clinic. An “index
o f difficulty” was calculated for each item by dividing the number of correct responses to
an item by the total number o f responses to that item If the value o f this index was
greater than .75, meaning that most patients answered the question correctly, that item
was either changed or eliminated.
The revised 37-question KQ was then given to a different group of 30 patients,
sixteen o f whom completed the questionnaire again four to six weeks later Test-retest
correlations and Cronbach’s alpha were calculated from this group. In addition, a
randomly selected group o f 56 patients from the colitis clinic (27 had Crohn’s disease and
29 had ulcerative colitis) completed the test for the reporting o f normative data.
The authors reported a Cronbach’s alpha o f .84 and a test-retest correlation of .92
for the revised KQ. The range o f test scores was 2-29, with an average score of 13.4 and
a standard deviation o f 6. The median score for Crohn’s patients was significantly higher
than the median score for ulcerative colitis patients (15 vs. 11, respectively). The KQ
score was negatively correlated with age (r= -.34, p<.01), and positively correlated with
the number o f years spent in full-time education (r= 49, p<001). In addition, the median
score o f the 13 people who were members o f the National Association o f Crohn’s
Disease and Colitis was higher than the rest o f the subjects (median =21, p< 005). The
authors conclude that the KQ is useful for assessing patient knowledge.
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The Relationship o f Social Support to HRQOL in Other Groups
Social support, which is needed for a variety o f challenging circumstances, has
two major functions (Krol, Sanderman, and Suurmeijer, 1993). First, there is a direct
effect o f meeting a person’s needs for affiliation. Other people also assist an individual
in marshaling cognitive and emotional resources for coping (a buffer effect). A person
diagnosed with a chronic disease will presumably have an increased need for both
functions o f social support in order to experience an optimal satisfaction with life.
Krol et al. (1993) reviewed research on the effects o f social support on quality of
life in patients with rheumatoid arthritis. Although they noted that most studies were not
adequately designed to establish a causal link between the two constructs, they concluded
that such support is beneficial. Similarly, a review o f 25 years o f research on lung cancer
(Montazeri, Gillis, & McEwen, 1998) ends with an exhortation for clinicians to pay
closer attention to a patient’s emotional needs because this attention, the authors claim,
can lead to an increased quality o f life in these patients. Studies o f people with diabetes
(Aalto, Uutela, & Aro, 1997) and chronic pain (Trief, Carnrike, & Drudge, 1995) have
yielded similar results.

The Relationship o f Social Support to HRQOL in IBD Patients
Since IBD is an illness without a cure— except for removal o f the colon in
ulcerative colitis—those who suffer from it are likely to frequently rely on emotional
support from others. Several recent studies have examined the role that social support
plays in helping IBD patients adapt to their illness. MacPhee, Hoffenberg, and
Ferranchak (1998) administered a generic quality o f life instrument to 18 ulcerative
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colitis patients and 12 suffering from Crohn’s disease (average age was 14 years). The
subjects also completed a measurement of satisfaction with present social support, and a
significant correlation between the two was reported (r=.46). The authors concluded that
quality o f life is better predicted by perceptions of social support than by disease activity.
Although these subjects were adolescents rather than adults, and a categorical as opposed
to a quantitative measure o f disease activity was used, the relationship of social support
to HRQOL in this study is clear.
In another study, Turnbull and Vallis (1995) administered the IBDQ and
quantitative measurements o f disease activity to sixteen patients with Crohn’s disease and
to six who had ulcerative colitis, reporting a nonsignificant correlation between disease
activity and HRQOL (r=.41). Scores from measurements o f psychosocial functioning,
psychological distress, and coping style were then combined with disease activity into a
single variable and used to predict the total and subscale scores o f the IBDQ The
measure o f psychosocial function (Sickness Impact Profile; Berger, Bobbitt, & Pollard,
1976) included questions about a person’s social interaction and communication with
others. The combined measurements were significantly related to the IBDQ total score
(r=.53, p<.05); increased HRQOL was associated with higher levels o f social functioning.
In a separate study. Maunder, de Rooy, Toner, Greenberg, Steinhart, McLeod, and
Cohen (1997) administered the RFIPC (Drossman et al., 1991) to over 200 IBD patients.
Two groups were formed; a Counseling group, composed o f people who had recently
sought or who were being referred for counseling, and a Noncounseling group, made up
o f patients who had not received counseling within the last six months. The authors
reported that two RFIPC items that pertained to social support, “being alone” and “being
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a burden to others,” were more o f a concern to those in the Counseling group. Assuming
that the people seeking counseling were experiencing greater distress than those who
were not, indirect evidence that difficulties with social support are related to increased
distress is provided. Presumably, increasing levels of psychological distress are also
related to decreased HRQOL (Drossman et al., 1991), thus showing a relationship
between social support and HRQOL.
Finally, Godber and Mayberry (1988) reported on a telephone support service
offered to members o f an IBD support group in Nottingham, England. The phone
counselors were IBD patients who had received a short course in counseling skills, and in
a period o f several months, 20 patients utilized these services. The most frequently
discussed topics were a need to talk with someone who understands the problems of IBD,
a feeling that a person’s doctor was not interested in these problems, and feeling too
embarrassed to discuss these problems with friends. Clearly, this group of people was
composed o f distressed individuals who were motivated enough to seek lay counseling,
and who may not be a representative sample o f IBD patients. In addition, no
measurements of HRQOL or social support were taken However, the importance o f
relationships with others to these people is clear, and the above studies suggest that the
investigation o f social support and HRQOL in IBD patients, using valid and reliable
measures o f these constructs, has promise for increased understanding o f their
relationship.
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M easurement o f Social Support
A subject’s satisfaction with social support was measured using the six-question
Social Support Questionnaire (SSQ6; Sarason, Sarason, Shearin, & Pierce, 1987). This
questionnaire was designed to provide a short (it can be filled out in a few minutes) and
psychometrically sound measure o f social support. It was based on the 27-question
Social Support Questionnaire (SSQ; Sarason, Leaven, Bash, & Sarason, 1983), which
will be described first.
The SSQ (Sarason et al., 1983, Study 1) was designed from a list o f 61 items
concerning social support that were formed from several studies containing hundreds of
college students. Items that had low correlations with other items were eliminated,
reducing the SSQ to 27 items. Each question asks the subject to (a) list the people whom
they rely on for support in certain circumstances and (b) report their satisfaction with
these social supports, resulting in the calculation o f two separate scales. The number
score (N) is simply the total number o f people listed. An average N score is obtained for
an individual by dividing the total N score by 27. Each item also receives a satisfaction
score (S), ranging from 1 (very dissatisfied) to 6 (very satisfied). The total S score is then
divided by 27 to produce an average S score.
The authors administered the SSQ to 602 college students. The average N score
was 4.25, and the average S score was 5.38. The Cronbach’s alphas o f the N and S scales
were .97 and .94, respectively. A factor analysis performed on each scale showed that a
single factor accounted for 82% o f the common variance in the N scale and another factor
accounted for 72% o f the common variance in the S scale. The correlation between the
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two scales was .34, supporting their treatment as separate concepts. The test-retest
correlations (four-week interval) for the N and S scales were .90 and .83, respectively.
After showing that the SSQ had good psychometric qualities, the authors
investigated its validity (Sarason et al., 1983, Study 2). The subjects were 100 male and
127 female college students. All were administered the SSQ and the Multiple Affect
Adjective Check List (MAACL; Zuckerman & Lubin, 1965). Four weeks later, 66 of
these subjects (28 men and 38 women) were administered the Extraversion and
Neuroticism scales o f the Eysenck Personality Inventory (EPI; Eysenck & Eysenck,
1968).
The authors reported significant correlations (r= -.26 to -.43) between both SSQ
scales and the Anxiety, Depression, and Hostility scales o f the MAACL for female
subjects. Similar but weaker correlations were found for men. Thus, people with higher
social support (measured by the SSQ) experienced lower negative affect. For females, a
significant correlation was also reported between the N score o f the SSQ and the
Extraversion scale of the EPI. Such a relationship was not found between the S score of
the SSQ and the Extraversion scale. For men, the results were in the same direction, but
were not significant. This is finding makes intuitive sense, since extraverts, by definition,
are likely to have many people to turn to.
Finally, there was a significant negative correlation among female subjects
between the S scale o f the SSQ and the Neuroticism scale o f the EPI, but a nonsignificant
relationship between the N scale o f the SSQ and the Neuroticism scale; that is, women
who were not satisfied with their social support reported more emotional disturbance.
Again, the results were similar, but not significant, in the group of men. These results are
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consistent with the findings— described above—that emotional distress is related to
difficulties with one’s social support system (Maunder et al., 1997). In summary, the N
and S scales o f the SSQ are internally consistent and stable, and are related in a
theoretically consistent way to measures o f negative affect and sociability.
The SSQ6 (Sarason et al., 1987) was designed to be a short measure of social
support that would correlate highly with the SSQ. It is composed o f six questions from
the SSQ, and takes less than 10 minutes to complete. These questions were selected
using data from two studies (Sarason et al., 1987) in which the subjects were several
hundred adults who had completed the SSQ and other measures of social support. The
six items o f the SSQ6 were chosen on the basis o f their high average loadings following a
factor analysis o f the SSQ.
A third sample o f subjects was used for cross-validation. An SSQ-6 score was
computed for each subject, and compared to his or her SSQ score. The correlation
between the SSQ-6 and the SSQ Number scales was .97. The correlation between the
SSQ-6 and SSQ Satisfaction scales was .96. The internal reliabilities for these the SSQ-6
scales were greater than .90. The authors also computed correlations between the SSQ-6
and several measures o f social support, which did not differ from the corresponding
correlations involving the SSQ. The authors concluded that the SSQ-6 is a satisfactory
measurement o f social support.

Purpose and Hypotheses
A great deal o f research has been done concerning the treatment of the physical
symptoms of IBD. Only recently, however, has attention been focused on the other areas
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o f functioning that it impacts— a person’s health-related quality o f life. This attention has
also increased in areas such as cancer, asthma, epilepsy, rheumatoid arthritis, angina,
diabetes and AIDS (Bowling, 1995). Despite the increased attention to this area in IBD,
few studies have used valid and reliable measurements to study the factors that are related
to HRQOL in this patient group. The purpose o f this study is to attempt to identify some
o f these factors. I f strong relationships are observed between these constructs and
HRQOL, future research could examine these variables in a manner that permits causal
inferences about them. A review o f research leads to the following hypotheses;
1) A person’s disease activity, health locus o f control beliefs, knowledge of his
or her illness, and satisfaction with social support will predict his or her
health-related quality o f life better than will disease activity alone;
2) Believing that one’s behavior is able to effect positive health outcomes will be
positively related to increased knowledge about inflammatory bowel disease;
3) Scores on a subject’s Social sub scale o f the IBDQ will be strongly and
positively related to his or her scores on the Satisfaction scale of the SSQ6;
4) The IBDQ will have reliable subscale scores and a reliable composite score,
and;
5) The four sub scale scores o f the IBDQ will be only moderately correlated to
each other.
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Chapter 2
Method

Participants
Participants were recruited from rural outpatient treatment facilities in Michigan
and Montana by gastroenterologists with whom the experimenter was acquainted. In
addition, subjects who responded to a posting on an Internet chat group and in an IBD
newsletter also participated. All were patients 18 or older who had a diagnosis o f either
Crohn’s disease or ulcerative colitis that was potentially confirmable by medical records
(although to protect anonymity, this was not done). Patients who had an ostomy bag
were excluded from the study. Based on related research, a medium effect size was
likely for this study; thus, to obtain a power of .80 with an alpha level o f .05, 84 subjects
would be needed (Cohen, 1992). Sixty-two subjects were actually recruited.

Materials
Demographic Questionnaire. Each subject completed a questionnaire that
gathered information about gender, age, and type and duration o f disease. It requires
approximately one minute to complete. See Appendix A for the Demographic
Questionnaire.
Health-Related Quality o f Life. The Inflammatory Bowel Disease Questionnaire
(IBDQ) was used to quantify health-related quality o f life (Guyatt et al., 1989). This
measure has 32 items, and it takes approximately 20 minutes to complete. The
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development o f this instrument, as well as data on its validity and reliability, were
described above See Appendix B for the IBDQ
Disease Activity. The Chapel Hill Index (CHI) was used to measure disease
activity (Sandler et al., 1988). The development and characteristics o f this instrument
were described above. This questionnaire contains three questions and it can be
completed in less than five minutes. See Appendix C for the CHI.
Health Locus o f Control. The 18-item Multidimensional Health Locus o f Control
Scale, Form C (MHLC-C) was used to measure to measure health locus of control
(Wallston et al., 1994). This measurement was described in detail above, and it requires
approximately 10 minutes to complete. See Appendix D for the MHLC-C
Patient Knowledge. The amount o f information that a patient knows about his or
her disease was assessed by a modified form o f the Patient Knowledge Questionnaire
(KQ; Jones et al., 1993). Information about this measurement’s development, validity,
reliability, and modification was given above. It has 37 items and takes about 15 minutes
to complete. The correct responses to the KQ were not indicated in the original article,
but were obtained by having the gastroenterologist from Montana complete it. See
Appendix E for the KQ.
Social Support. The six-item Social Support Questionnaire (SSQ-6) was used to
measure each patient’s satisfaction with social support (Sarason et al., 1987). Its
development and validity and reliability information were described above. This
instrument can be completed in approximately 10 minutes. See Appendix F for the
SSQ-6.
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Procedure
Approval by the Institutional Review Board was obtained before this study began
(Appendix G). Many o f the participants were recruited by a gastroenterologist or nurse
who briefly explained the study to consecutive patients at an outpatient clinic in either
Marquette, Michigan or Missoula, Montana during regularly scheduled visits. A packet
containing the questionnaires was then distributed to those who both wished to participate
and who met the exclusion criteria. Those who declined were not asked again. To
minimize the amount o f time spent explaining the study, detailed instructions were
included with each packet (Appendix H), and they were also printed at the top each
instrument.
Participants who wished to participate completed the questionnaires at home, with
a total time to read and complete the packet o f approximately one hour. To ensure
complete anonymity, the instructions stated that subjects were not to write their names on
any o f the questionnaires. Each packet contained a postage-paid, addressed envelope,
which was mailed to the principal investigator at the University o f Montana. When the
questionnaires were received, a number code was assigned to all questionnaires in a
packet to prevent any possibility that they would be confused with each other. In order to
minimize the time demands on the gastroenterologist, the campus phone number o f the
principal investigator was included in the instructions. Thus, subjects had the opportunity
to leave their first names and a number where they could be reached if they had any
questions.
In order to increase the sample size of this study, subjects were recruited from two
additional sources. First, a brief description o f the study was posted on an Internet
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message board, asking any interested people to respond to the e-mail address of the
experimenter. Those who responded were then sent a more detailed message that
emphasized the anonymity o f the study, explained the exclusion criteria, and asked—if
they were eligible and still interested— for an address to which the study could be mailed
via the U.S. Postal Service. When an address was received, a questionnaire pack was
sent and the address was deleted from the computer. In addition, a brief description of
the study was placed in an IBD newsletter (Appendix K). Interested persons responded
with an address by either e-mail or traditional mail, and a questionnaire packet was sent
to them. All o f these packets and the instructions were identical to the ones distributed in
the doctor’s office.
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Chapter 3
Results

Sample Characteristics
All data were scored and entered into a computer equipped with SPSS, then
double-checked for accuracy in both scoring and entering. A total o f 113 questionnaires
were distributed either directly or by mail, o f which 62 (55%) were received and used for
this study. Breaking this down according to source, thirty were received from Michigan,
two were received from Missoula, seven came from Internet subjects, and twenty-three
came from responders to the IBD newsletter.
Table 1 displays the sample’s demographic characteristics. Seventy-three percent
o f the subjects were diagnosed with Crohn’s disease, and o f the 59 subjects who
indicated their gender, 43 (73%) were female. All but one were Caucasian, and the mean
age and years since diagnosis o f the sample were similar to those reported in a recent
study (Slonim, Bulone, Damore, Goldberg, Wingertzahn, and McKinley, 2000).
In Table 2 are the range, mean and standard deviation o f the scales and subscales.
Most o f the scales did not appear normally distributed; however, the SSQ-6 and the
IBDQ Social subscale were particularly skewed in a positive direction. The average
Chapel Hill Index score was 187.8, a value equivalent to a moderate level o f disease
activity (Best et al. 1976; Sandler, Jordan, and Kupper, 1988). This score was slightly
lower than the baseline score o f subjects in a recent trial o f growth hormone therapy for
Crohn’s disease (Slonim et a l, 2000). In two other studies the pretreatment means were
approximately 300 (Targan, Hanauer, van Deventer, Mayer, Present, Braakman,
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DeWoody, Schaible, and Rutgeerts, 1997; Yacyshyn et al., 98). The average IBDQ Total
score was 152.4, slightly lower than the “in remission” group (that is, people with a low
level o f disease activity) means o f 169.0 and 174.0 reported by Irvine (1997) and Han et
al. (1998), respectively.

Table 1: Demographic Characteristics of 62 IBD Patients.
Characteristic
Crohn’s disease
Male
Female
Ulcerative colitis
Male
Female
Age in years
Mean (SD)
Range
Years since diagnosis
Mean (SD)
Range
Source
Michigan
Missoula
Internet
Newsletter

Number of Subjects
45*
10
32
17
6
11
46 (17)
20-80
15 (12)
1-48
Number (% who responded**)
30 (50%)
2(18% )
7 (54%)
23 (79%)

* Three subjects with Crohn’s disease did not report gender
** This is the percentage o f subjects from each source who mailed back a questionnaire,
not the percentage each source contributes to the sample

The average Multidimensional Health Locus o f Control-Internal score was
slightly higher (20.2 vs. 17.7) than it was in a sample o f arthritis patients (Wallston et al,
1994). The average Knowledge Questionnaire score was 19.0, higher than the 13.4
reported during the test’s development (Jones et al, 1993). Finally, the mean score of 5.2
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for this sample’s SSQ-6 Satisfaction score was only slightly lower than that reported for
the original SSQ6 (5 .4; Sarason et al., 1983). The most common sources o f social
support reported by subjects were friends (60%), parents (50%), spouses (44%), siblings
(39%), and children (35%). Other responses were employer (8%), doctor (6%), and God
(3%).

Table 2: Mean, Standard Deviation, Range, and Total Possible of the Scales.
Instrument

Mean

SD

Ranee

Total

CHI*
MHLC-I
KQ
SSQ-6
IBDQ Bowel**
IBDQ Systemic
IBDQ Emotion
IBDQ Social
IBDQ Total

187.8
20.2
19.0
5.2
49.0
20.9
55.8
26.7
152.4

131.2
6.7
5.9
1.2
12.1
7.5
16.6
8.0
40.9

0-513
6-36
9-30
1.2-6.0
17-69
7-35
22-82
8-35
59-220

650
36
37
6.0
70
35
84
35
224

*Higher scores indicate greater disease activity; ** For IBDQ, higher scores indicate
better fimctioning; CHI = Chapel Hill Index; MHLC = Multidimensional Health Locus of
Control-Internal Scale; KQ = Knowledge Questionnaire; SSQ-6 = Social Support
Questionnaire (Satisfaction Scale)

Hypothesis One
The first and major hypothesis o f this study was that disease activity, health locus
o f control beliefs, knowledge o f illness, and satisfaction with social support would predict
a person’s HRQOL better than will disease activity alone. This was tested by first
forcing disease activity (the Chapel Hill Index) into a regression equation in a
hierarchical fashion (Step 1). The remaining predictors (the Multidimensional Health
Locus o f Control-Internal scale, the Knowledge Questionnaire score, and the Satisfaction
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scale o f the SSQ-6) were then entered together as a group, and the computer was
instructed to proceed in a stepwise fashion (Step 2). The dependent variables in the five
resulting regression equations were the IBDQ Total score and each o f the IBDQ subscale
scores (Bowel, Systemic, Emotional, and Social).
Table 3 shows the results o f the five regression analyses. As expected, the Chapel
Hill Index accounted for a significant amount o f variance in all o f the IBDQ subscale
scores and in the IBDQ Total score, with R-squared in Step 1 ranging from .43- 67. The
only other significant predictor was the SSQ-6 Satisfaction scale for the Emotion
sub scale, accounting for an additional eight percent o f the subscale variance.

Hypothesis Two
The second hypothesis was that believing one’s behavior is able to effect positive
health outcomes will be positively related to increased knowledge about IBD This was
tested by calculating a Pearson’s correlation coefficient between the Internal scale of
Multidimensional Health Locus o f Control questionnaire and the Knowledge
Questionnaire. The correlation coefficient (one-tailed) was not significant (r = -.16,
P>.05).

Hypothesis Three
The third hypothesis was that the Social subscale of the IBDQ would be strongly
and positively related to the Satisfaction scale o f the SSQ-6. This was tested by
calculating a Pearson’s correlation coefficient between the Social subscale o f the IBDQ
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and the Satisfaction scale o f the SSQ-6. The correlation coefficient (one-tailed) was
significant (r =.33, p<.05), and the value o f

was .11.

Table 3: Regression Analyses for IBDQ Subscales and Total Score.
Bowel Subscale
Steu* Variable Entered
1

cm

Constant
Svstemic Subscale
Sten* Variable Entered
1

cm

Constant
Emotion Subscale
Sten* Variable Entered

B

T
-10.7
40.0

P

nr^

sr*

Total R=

.00
.00

.67=

.67=

.67=

B

T

P

sri

Total

-.038
28.2

-6.8

.00
.00

.44=

.44=

.44=

B

T
-6.7

p

pf:
.43=

Sri
.43=

Total R:

-5.8
3.0

.37=
.14=

.29=
.08=

-.075
63.2

22.1

.00

.43=

1

cm

-.008

2

cm

-.007
4.0
49.1

6.2

.00
.00
.00

B

T

p

pr=

sri

Total R2

-.004
34.8

-7.9
28.2

.00
.00

.52=

.52=

.52=

B

T

p

Total R:

-9.2
33.9

.00
.00

pr^
.59=

sr^

-.24
197.9

.59=

.59=

SSQ-6
Constant
Social Subscale
Steo* Variable Entered
1

cm

Constant
Total Score
Sten* Variable Entered
1

cm

Constant

51=

®significant at .05 level; pri = squared partial correlation; sri = squared semipartial correlation
*In Step 1 and Step 2 the C m was entered hierarchically, and in Step 2 the SSQ-6 was entered in a
stepwise fashion; Cffi = Chapel m il Index; SSQ-6 = Social Support Questionnaire (Satisfaction Scale)

Hypothesis Four
The fourth hypothesis was that the IBDQ would have reliable subscale scores and
a reliable composite score. This was tested by calculating Crohnbach’s alphas for each of
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the four subscales and for the composite score o f the IBDQ. These values were as
follows: Bowel (.86), Systemic (.85), Emotion (.95), Social Function (.90), and Total
score (.97). These results were higher than those reported by Han et al. (1998) for the
EBDQ subscales. They reported the following alphas: Bowel (.81), Systemic (.72),
Emotion (.89), and Social (.89). The alpha for Total score was not given. Appendix I
displays the items o f the IBDQ categorized according to subscale.

Hypothesis Five
The fifth hypothesis was that the four subscale scores o f the IBDQ will be only
moderately correlated to each other. This was tested by calculating the Pearson’s
correlations between each o f the four subscales, and between each sub scale and the
composite score. Table 4 displays these correlations, which ranged from .77 between the
Bowel and Systemic subscales to .96 between the Emotion subcale and the Total Score.
All o f the correlations were significant. To date, no other studies have reported the scale
intercorrelations o f the IBDQ, although Han et al. (1998) reported an average item-total
correlation o f .67.

Table 4: Scale Intercorrelations of the IBDQ.*
Bowel
Bowel
Systemic
Emotion
Social
Total

.77
.80
.76
.91

Systemic

Emotion

Social

Total

—

—

—

—

—

—

—

——

—

.89

—

.87
.76
.91

.82
96

* All correlations were significant (two-tailed)
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Back to Hypothesis One: Nonsignificant Predictors
In an effort to find possible reasons why most o f the additional predictors were
not significant in the regression equations for the first hypothesis, several other analyses
were carried out. First, a close look was given to the probability values o f the r-tests for
each o f the excluded variables in the regression analyses. This was done to determine if
the study had low power, and to ascertain whether any o f the variables were approaching
significance, as well as what their partial correlation coefficients were. Table 5 displays
the probabilities and partial correlation coefficients of the excluded variables in each of
the five regression equations. The probabilities ranged from .08-. 89, with an average
value o f .49, and the squared partial correlation coefficients ranged from .00- 05.
After this, the years since diagnosis, sex and age o f the subjects were entered
hierarchically into five separate regression equations (IBDQ subscale scores and the
Total Score), with sex coded as a dummy variable (0=female, l^male). None of these
three predictors accounted for significant variance in any o f the EBDQ subscales or in the
Total score.
In the next post-hoc analysis, the Chapel Hill Index and the SSQ-6 were entered
together into a regression equation to determine the amount o f variance in IBDQ scores
they accounted for together. The Chapel Hill Index score and the SSQ-6 score were then
multiplied to create an interaction score for each subject. Finally, the interaction score
was entered into the equation to establish whether it accounted for any significant
additional variance. This was done to determine whether the SSQ-6 was a better
predictor o f HRQOL at, for example, lower versus higher levels o f disease activity. The
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Table 5: Probabilities and Partial Correlation Coefficients of Excluded
Variables in the Five Regression Equations.
Dependent Variable

Excluded Variable

t*

p

pr**

pr^

IBDQ Bowel

KQ
SSQ-6
MHLC

.14
-.39
.76

.89
.70
.45

.02
-.05
.10

.00
.00
.01

IBDQ Systemic

KQ
MHLC
SSQ-6

-.69
.95
1.2

.50
.35
.23

-.09
13
.16

.01
.02
.03

IBDQ Emotion

KQ
MHLC

.19
.50

.85
.62

.03
.07

.00
.00

IBDQ Social

KQ
SSQ-6
MHLC

.40
1.3
1.5

.70
.20
.13

.05
.17
.20

.00
.03
.04

IBDQ Total

KQ
MHLC
SSQ-6

.23
.97
1.8

.82
.34
.08

.03
.13
.23

.00
.02
.05

* t= t-test; ** pr= partial correlation coefficient
KQ= Knowledge Questionnaire; MHLC= Multidimensional Health Locus o f Control
Scale-Internal; SSQ-6 = Social Support Questionnaire (Satisfaction Scale)
..

same procedure was repeated for each IBDQ subscale and for the Total score Table 6
displays the results o f the five regression equations. The Interaction score significantly
increased the R-squared value only for the Emotion subscale (4%), and it accounted for
approximately eight percent o f unique variance (not shown in table).
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Table 6: Interaction Between Disease Activity and Social Support.
IBDO Subscale
Bowel
Systemic
Emotion
Social
Total

Sten 1 fRzi
67*
.46*
.51*
.53*
.61*

Step 2
.67*
.48*
.55*
.53*
.63*

R^ increase
.00
.02
.04*
.00
.02

®significant at .05 level
Step 1 = Chapel Hill Index and SSQ-6 Entered; Step 2 = Interaction Score Entered

Finally, the subjects were divided into two groups based on diagnosis to address
the possibility that the regression predictions would be supported for people with either
Crohn’s disease or ulcerative colitis, but not in a mixed sample. To examine this
possibility, the regression analysis was repeated separately on the 17 subjects diagnosed
with ulcerative colitis and on the 45 diagnosed with Crohn’s disease (Table 7). The
Chapel Hill Index accounted for more variance in all o f the IBDQ scales for the subjects
with ulcerative colitis. The SSQ-6 also accounted for a greater portion of unique
Emotion subscale variance in the ulcerative colitis subjects (.07 vs. .27). Finally, the
SSQ-6 accounted for 30% o f unique Total score variance in the ulcerative colitis patients,
compared to a nonsignificant amount in the Crohn’s disease subjects. Appendix J
displays the means and standard deviations for the scales for each group.
To determine whether the Multidimensional Health Locus of Control-Internal
Scale (MHLC) or the Knowledge Questionnaire were approaching significance in any of
the regression equations for the ulcerative colitis patients, the probability values and
partial correlation coefficients for each of these excluded variables were examined (Table
8). If a more liberal p-value o f . 10 was adopted, the SSQ-6 and the MHLC would
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become additional significant predictors in three o f the subscales. For the Bowel
sub scale, the SSQ-6 accounted for 18% of unique variance. In addition, the MHLC
accounted for 20% and 21% o f unique variance in the Social and Total scales,
respectively.

Table 7: Regression Analyses for Crohn’s Disease vs. Ulcerative Colitis
Bowel Subscale
Step
Variable Entered*

Crohn’s disease
pr®
sr®
Total R®
.59"
.59*
.59*

Ulcerative colitis
nr®
sr®
Total R®

Systemic Subscale
Sten
Variable Entered

Crohn’s disease
nr®
sr®
Total R®

Ulcerative colitis
pr®
sr®
Total R®

1

.34*

.62*

1

cm

cm

.34*

.34*

.76*

.76*

.62*

.76*

.62*

Emotion Subscale
Sten
Variable Entered

Crohn’s disease
or®
sr®
Total R®

Ulcerative colitis
or®
sr®
Total R®

1
2

.37*
.35*
11*

.49*
.11*
.53*

cm
cm

SSQ-6

.37*
.30*
.07*

.37*
.44*

.49*
.03*
.27*

.49*
.76*

Social Subscale
Step
Variable Entered

Crohn’s disease
pr®
sr®
Total R®

Ulcerative colitis
or®
sr®
Total R®

1

.45*

.64*

cm

.45*

.45*

.64*

.64*

Total Score
Sten
Variable Entered

Crohn’s disease
or®
sr®
Total R®

Ulcerative colitis
pr®
sr®
Total R®

1
2

cm
cm

.51*
.51*

.51*
.51*

.51*

SSQ-6

.03?

t

.51*

.72*
.50*
.30*

.72*
.19*
.08*

.72*
.80*

®significant at .05 level; f not significant; t not in printout; p f = squared partial correlation; sri = squared
semipaitial correlation; CHI = Chapel Hill Index; SSQ-6 ==Social Support Questionnaire (Satisfaction
Scale); *In Step 1 and Step 2 the CHI was entered hierarchically, and in Step 2 the SSQ-6 was entered in a
stepwise fashion
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Table 8: Probabilités and Partial Correlation Coefllcients for Excluded
Variables in Ulcerative Colitis Patients.
Dependent variable

Excluded variable

t*

p

pr**

pr^

IBDQ Bowel

KQ
MHLC
SSQ-6

-.90
1.7
1.8

.38
.11
.10

-.23
.42
.43

.05
.18
.18

IBDQ Systemic

SSQ-6
KQ
MHLC

.36
-1.6
1.7

.72
.14
.12

.10
-.38
.41

.01
.14
.17

IBDQ Emotion

KQ
MHLC

-.80
1.0

.44
.32

-.22
.27

.05
.07

IBDQ Social

KQ
SSQ-6
MHLC

-.68
.83
1.9

.51
.42
.08

-.18
.22
.45

.03
.05
.20

IBDQ Total

KQ
MHLC

-1.2
1.8

.23
.10

-.33
.46

.11
.21

* p= t-test; * * pr= partial correlation coefficient
c m = Chapel Hill Index; KQ = Knowledge Questionnaire; MHLC = Multidimensional
Health Locus o f Control Scale-Internal; SSQ-6 - Social Support Questionnaire
(Satisfaction Scale)
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Chapter 4
Discussion

Hypothesis One
Social support This study confirms that disease activity is related to HRQOL, a
finding that is consistent with previous research (Irvine et al., 1994; Vallis and Turnbull,
1996). The major hypothesis o f this study, however, was that a person’s disease activity,
health beliefs, knowledge o f illness, and satisfaction with social support would predict his
or her HRQOL better than would disease activity alone. Possible reasons for the
nonsignificance o f health beliefs and knowledge o f illness will be discussed below, but
first the relationship o f social support to HRQOL will be discussed.
The SSQ-6 was a significant predictor for the Emotion subscale o f the IBDQ
(Table 3). This finding is consistent with research in areas such as lung cancer
(Montazeri et al., 1998) and diabetes (Aalto et al., 1997), and it also supports findings
with IBD patients (MacPhee et al., 1998; Maunder et al., 1997). The present study has
refined the understanding gained by previous research in IBD, however, by overcoming
two methodological limitations.
First, a quantitative rather than a categorical measure o f disease activity was used,
and a disease specific rather than a generic HRQOL instrument was employed, allowing
for a more precise description o f the relationship between social support, disease activity,
and HRQOL. Second, satisfaction with social support was measured with a wellvalidated and reliable instrument, rather than a composite score based on psychosocial
functioning, psychological distress and coping style (Turnbull and Vallis, 1995).
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Specifically, the present study suggests that satisfaction with social support is
related to the emotional aspect o f HRQOL in IBD (Table 3). In addition to depression,
the Emotion scale asks about anxiety, worries related to having IBD, embarrassment,
anger, and feeling misunderstood by others (Appendix J). This relationship suggests that
having people to talk to about the feelings associated with IBD is important, because
many o f the symptoms— abdominal pain and rectal bleeding for example—are
embarrassing and could isolate a person in his or her suffering.
Based on this finding, several interventions may be helpful. Some people may
benefit from learning communication skills specifically aimed at proper disclosure of
symptoms. For example, a person would describe their discomfort differently to a spouse
than to an employer. In addition, certain individuals may receive encouragement fi'om a
support group, which could be either face-to-face or through an online chat room.
Advantages to an online group include easy accessibility (to those with computers) and
anonymity. Doctors who deal regularly with IBD patients would do well by being aware
o f and referring to both types o f support groups in their cities.
Health locus o f control. Health locus o f control (HLOC) and patient knowledge
were not significant predictors o f any aspect o f HRQOL (Table 3). In chronic illnesses
such as osteoarthritis and chronic pain, a relationship between HLOC and psychological
adjustment has been demonstrated (e.g., Crisson and Keefe, 1988; Laborde and Powers,
1985). It was assumed for this study both that psychological adjustment was an aspect of
HRQOL (Farquhar, 1995), and that the active coping methods used by some IBD patients
(Kinash et al., 1993) are prompted by the belief that one’s actions to a large extent
determine health.
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The negative findings o f this study in regards to HLOC, however, are similar to
the research by Smolen and Topp (1998), who did not find a strong relationship between
problem-focused coping styles and well-being, a concept related to HRQOL (Farquhar,
1995). Andrykowski and Brady (1994) have suggested that health beliefs become more
important to adjustment when the perceived threat o f the disease is great. It may be that
sufferers o f IBD view their illness more as a nuisance than a great threat to their health
It may also be the case that psychological adjustment— a vague term to be certain—is not
an important aspect o f HRQOL as defined by the IBDQ. Future research on HRQOL
should clearly define the construct, and it should not interchange terms such as well
being or health status for HRQOL (Anderson and Burckhardt, 1999).
Knowledge o f illness. A patient’s knowledge o f his or her illness is related to
HRQOL in conditions such as chronic pain (Lefort et a l , 1998) and diabetes (Glasgow,
1995), and studies with IBD patients have suggested a similar link (Moser et al., 1995;
Smart et al, 1986). The present study, however, did not offer support for the relationship
between knowledge and HRQOL over and above the effects of the Chapel Hill Index
(Table 3). There are at least two possible reasons for this discrepancy.
First, the symptoms o f IBD are qualitatively different than conditions like chronic
pain. Education programs for chronic pain often teach coping techniques such as
relaxation (LeFort et al., 1998) and present information about the physiology of pain.
These programs are successful at addressing the physical symptoms of chronic pain, and
have a corresponding effect on HRQOL (LeFort et al., 1998). Because of the nature of
Crohn’s disease and ulcerative colitis, however, similar programs for IBD have not been
successful at addressing physical symptoms (Schwartz and Blanchard, 1991). Thus,
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although knowledge may help reduce the suffering involved in chronic pain, it apparently
has little effect on the symptoms o f IBD.
The second possibility for the discrepancy between this study and previous
research concerning patient knowledge is that past studies with IBD patients have used
less rigorous methodologies. Moser et al. (1995) and Smart et al (1986) reported a
relationship between disease knowledge and HRQOL, however, they had subjects
estimate their knowledge rather than complete an objective measure. It may be that what
a person thinks (s)he knows and what (s)he actually knows are different. Further, Jones
et al. (1993) reported that about 20-30% o f people do not want more information about
IBD. Future research could examine the role o f disease knowledge on HRQOL in the
subgroup o f patients who strongly desire more information.

Hypothesis One: Additional Analyses Concerning the Nonsignificant Predictors
Although the modest contribution of social support and the nonsignificant
contributions o f HLOC and patient knowledge to HRQOL may have occurred for the
reasons mentioned above, additional analyses were done to determine if future research
should investigate a modified version o f the first prediction. An analysis o f the sample
(Table 2) reveals that subjects had, on the average, moderate disease activity and a
correspondingly diminished HRQOL. On these variables, as well as for age and years
since diagnosis (Table 1), the sample was similar to other groups reported in the
literature. Thus, this sample appears to be fairly representative o f the population of IBD
patients, at least of those who are Caucasian. In addition, although most o f this group
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was female, sex accounted for a nonsignificant proportion o f variance in the IBDQ
subscales and the Total score, as did the years since diagnosis and age of the subjects.
Despite the fact that, with a larger sample, health beliefs and disease knowledge
may have been significant predictors, the actual amount of variance they would account
for would likely have been quite small compared to disease activity and, to a lesser
degree, satisfaction with social support. Whereas the values of R-squared for the Chapel
Hill Index ranged from .43- 67 (Table 3), the squared partial correlations for health
beliefs or disease knowledge were very small (pr^ ranged from .00-.04; Table 5), and the
corresponding values for the SSQ-6 ranged from .00-.05. It does not appear, therefore,
that the failure to confirm the major hypothesis was merely due to insufficient statistical
power.
Similarly, level o f disease activity did not play a major role in prediction of
HRQOL. With the exception of the Emotion subscale, the interaction variable (disease
activity X social support) did not add significantly to R-squared, and it added only 4% to
the Emotion subscale (Table 6). Thus it was not the case that the major hypothesis was
confirmed at only certain (e.g., lower) levels o f disease activity.
The choice o f disease activity scale could have contributed to the lack of support
for the major hypothesis. Previous research (Irvine et al., 1994) has shown that the
Crohn’s Disease Activity Index (and thus the Chapel Hill Index) and the IBDQ Total
score are highly correlated, most likely because both ask for subjective symptoms of IBD
(Appendices B and C). The use o f an objective disease activity scale may have produced
results that supported the major hypothesis.
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Beside the possibility that the null hypothesis is true, however, the most likely
explanation for the lack o f support for the major hypothesis is that grouping both Crohn’s
disease and ulcerative colitis patients together obscured the results Disease activity was
a better predictor for every aspect o f HRQOL for subjects with ulcerative colitis and,
similarly, social support was a better predictor for the Emotion and Total scales (Table 7).
In addition, health beliefs approached significance in both the Social and Total scales
(Table 8). The fact that these variables were significant or close to significant in a
sample o f only 17 subjects strongly suggests that more research be done to examine the
relationship o f these variables to HRQOL in ulcerative colitis patients.
This analysis, although post-hoc, is consistent with research showing that Crohn’s
patients have diminished HRQOL compared to ulcerative colitis patients (Drossman et
al., 1989; Farmer, Easley, and Farmer, 1992), and that the two groups have different
disease-related concerns (Drossman et al., 1991). Although Drossman et al. (1991)
explained the impairment in Crohn’s disease in terms o f greater disease activity, this
study did not support that interpretation. Before concluding, however, that the lack of
support for the major hypothesis is due to a “Crohn’s personality style,” that is, a passive
or dependent manner o f relating to others, it should be noted that such speculation has not
been consistently supported (North and Alpers, 1994). It may be that people with
ulcerative colitis experience symptoms that are slightly different than those of Crohn s
sufferers (e.g., weight loss vs. fatigue), and that they are better able to manage the impact
that their illness has on their lives. A better understanding o f this process could lead to
interventions that would increase the HRQOL o f people with Crohn’s disease and
ulcerative colitis alike.
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Hypothesis Two
The second hypothesis—believing that one’s behavior is able to effect positive
health outcomes will be positively related to increased knowledge about IBD—was not
confirmed. The original rationale for this hypothesis was that an internal HLOC may
prompt people to learn more about their illness, or, alternatively, having a lot of
knowledge about IBD may cause one to feel more in control o f the illness. Both
interpretations were based on Kinash et al s (1993) research showing that maintaining
control and gathering information were commonly used coping strategies in IBD patients.
The fact that these two constructs were not related to each other is consistent with
the finding by Smolen and Topp (1998) that a positive outlook (optimism), not more
active strategies, is related to well-being. It may be that an interaction between optimism,
HLOC, and knowledge o f illness exists, a possibility that future research could
investigate The data in this study, however, suggest that health beliefs and knowledge of
illness are not related.

Hypotheses Three, Four and Five
Hypothesis Three. The last three hypotheses deal with certain psychometric
properties of the IBDQ and, therefore, will be treated together. The third hypothesis was
that the Social subscale o f the IBDQ will be strongly and positively related to the
Satisfaction scale o f the SSQ-6. Such an association would help to establish the
concurrent validity o f the IBDQ’s sub scale, which is important, because the validity of
this scale has not yet been firmly established.
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In this study, the relationship between the two scales was a significant but
moderate (r = .33) correlation; thus there is some support for the concurrent validity of
the Social sub scale o f the EBDQ. Although a higher correlation was anticipated, a close
look at the content o f the items in the two measures reveals some differences between
them. The SSQ-6 (Appendix F) asks for a list of people who are, for example,
dependable when help is needed, and how satisfied they are with their support. The
IBDQ Social subscale (Appendix I), however, asks about how having IBD has limited
one’s ability to attend social events such as school, work, or leisure activities. It is
possible for a person with IBD to have a severely restricted social life (and a
correspondingly low Social subscale score), yet still be relatively satisfied with his or her
social support. This satisfaction could occur by means o f an accommodating support
system; for example, the healthy husband could stay home with his wife who is too ill
with IBD to attend, thus preserving social satisfaction in spite of social limitations.
It is a mistake, therefore, to assume that, because a person with EBD is restricted
in their ability to engage in activities outside the home, they are also dissatisfied with
their social support. Acknowledging this point can lead to creative ways o f increasing
social support to individuals with severe disease activity, and it also highlights the
importance of educating friends and family members about IBD, so that they can help the
person with EBD compensate for their illness. Thus, the Social subscale of the IBDQ
appears to have utility as a way to quantify how impacted a person’s social life is by IBD,
although it may not give a clear indication o f satisfaction with social support.
Hypothesis Four. Although previous research has shown that the individual
sub scales have sufficiently high Crohnbach’s alphas, the total score has not received this
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attention. In this study, the alpha coefficient for the total score was .97, supporting the
use o f the composite score as a way o f providing an overall picture o f a person’s
HRQOL
Hypothesis Five. All o f the scale intercorrelations were very high, and because
the lowest correlation was .76 (Table 4), there is some question concerning the treatment
o f the scales as measuring separate constructs. It may be that all o f the scales measure a
common aspect of having IBD such as depression, an emotion frequently reported by
IBD patients (Mitchell et al., 1988). As discussed above, the Emotion subscale asks
about depressive symptoms, such as discouragement, tearfulness and life dissatisfaction
(Appendix I), and the Systemic subscale inquires into symptoms such as fatigue and
sleep and appetite disturbances. In addition, the Social subscale describes diminished
social interactions, which some researchers (Bellack, Hersen, and Himmelhoch, 1981;
Hoberman, 1990) have linked to depression. It is at least plausible that depression could
account for a sizeable portion o f variance in all of the subscales. Future research using
the EBDQ should include a measure o f depression such as the Beck Depression Inventory
(Beck, Ward, Mendelson, Mock, and Erbaugh, 1961) to address this question. Until that
is done, the utility o f using the IBDQ to discuss distinct components of HRQOL is
uncertain.

Final Conclusion
Although this study provided some insights into HRQOL in IBD patients, it also
raised many questions, a fact reflecting the relatively small amount o f research that has
been done in this area. (Maunder et al., 1995). Future research should begin with a clear
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definition o f HRQOL as a construct distinct from terms such as well-being and health
status, and the use o f disease activity measures that covers both the objective and
subjective physical symptoms o f IBD should be considered. In addition, it may be wise
to reconsider the utility o f grouping both Crohn’s disease and ulcerative colitis subjects
together for HRQOL research, because the two groups appear to be impacted differently
by the illnesses. Although the IBDQ is currently the best instrument for this type of
research, its ability to define discrete zireas o f HRQOL has not been sufficiently
demonstrated. More definite answers in this area are essential for assisting people in
adapting to the life-changing experience of IBD
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APPENDIX A
DEMOGRAPHIC QUESTIONNAIRE
Gender;
Age:
Ethnicity (circle one): Caucasian
Hispanic
Native American

African-American
Other

Type o f illness (circle one):

Ulcerative colitis

Crohn’s disease

Duration o f illness (how many years or months you have had it):___ _
Have you ever had surgery because of your Crohn’s disease or ulcerative colitis?
If yes, list d ates:________________________________________________
Current medications and dosages (please list ALL that you are taking, even if they are not
for Crohn’s disease or ulcerative colitis):
Medication:
Dosage:
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APPENDIX B
THE INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE (IBDQ)
This questionnaire asks questions concerning the impact o f Crohn’s disease or ulcerative
colitis on various areas o f your life. There are no right or wrong answers, so just answer
as honestly as you can
Please indicate how you feel about each item by circling a number from 1 to 7 in the
space provided. A 1 indicates that the area o f your life is a current difficulty. A 7 means
that the area o f your life is not a current difficulty. (NOTE: The actual IBDQ has a card
for each question that explains in detail what each number means).
1. How frequent have your bowel movements been during the last two weeks?
(Current difficulty)
1
2
3
4
5
6
7 (Not a difficulty)
2. How often has the feeling o f fatigue or o f being tired and worn out been a problem
for you during the last two weeks?
(Current difficulty)
1
2
3
4
5
6
7 (Not a difficulty)
3. How often during the last two weeks have you felt frustrated, impatient, or restless?
(Current difficulty)
1
2
3
4
5
6
7 (Not a difficulty)
4. How often during the last two weeks have you been unable to attend school or work
because of your bowel problem?
(Current difficulty)
1
2
3
4
5
6
7 (Not a difficulty)
5. How much of your time during the last two weeks have your bowel movements been
loose?
(Current difficulty)
1
2
3
4
5
6
7 (Not a difficulty)
6. How much energy have you had during the last two weeks?
(Current difficulty)
1
2
3
4
5
6

7 (Not a difficulty)

7. How often during the last two weeks did you feel worried about the possibility of
needing to have surgery because o f your bowel problem?
(Current difficulty)
1
2
3
4
5
6
7 (Not a difficulty)
8. How often during the last two weeks have you had to delay or cancel a social
engagement because o f your bowel problem?
(Current difficulty)
1
2
3
4
5
6
7 (Not a difficulty)
9. How often during the last two weeks have you been troubled by cramps in your
abdomen?
(Current difficulty)
1
2
3
4
5
6
7 (Not a difficulty)
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10. How often during the last two weeks have you felt generally unwell?
(Current difficulty)
1
2
3
4
5
6
7 (Not a difficulty)
11. How often during the last two weeks have you been troubled because o f fear of not
finding a washroom?
(Current difficulty)
1
2
3
4
5
6
7 (Not a difficulty)
12. How much difficulty have you had, as a result o f your bowel problems, doing leisure
or sports activities you would have liked to have done during the last two weeks?
(Current difficulty)
1
2
3
4
5
6
7 (Not a difficulty)
13. How often during the last two weeks have you been troubled by pain in the abdomen?
(Current difficulty)
1
2
3
4
5
6
7 (Not a difficulty)
14. How often during the last two weeks have you had problems getting a good night’s
sleep, or been troubled by waking up during the night?
(Current difficulty)
1
2
3
4
5
6
7 (Not a difficulty)
15. How often during the last two weeks have you felt depressed or discouraged?
(Current difficulty)
1
2
3
4
5
6
7 (Not a difficulty)
16. How often during the last two weeks have you had to avoid attending events where
there was no washroom close at hand?
(Current difficulty)
1
2
3
4
5
6
7 (Not a difficulty)
17. Overall, in the last two weeks, how much o f a problem have you had with passing
large amounts o f gas?
(Current difficulty)
1
2
3
4
5
6
7 (Not a difficulty)
18. Overall, in the last two weeks, how much o f a problem have you had maintaining, or
getting to, the weight you would like to be at?
(Current difficulty)
1
2
3
4
5
6
7 (Not a difficulty)
19. Many patients with bowel problems often have worries and anxieties related to their
illness. These include worries about getting cancer, worries about never feeling any
better, and worries about having a relapse. In general, how often during the last two
weeks have you felt worried or anxious?
(Current difficulty)
1
2
3
4
5
6
7 (Not a difficulty)
20. How much of the time during the last two weeks have you been troubled by a feeling
o f abdominal bloating?
(Current difficulty)
1
2
3
4
5
6
7 (Not a difficulty)
21. How often during the last two weeks have you felt relaxed and free of tension?
(Current difficulty)
1
2
3
4
5
6
7 (Not a difficulty)
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22. How much o f the time during the last two weeks have you had a problem with rectal
bleeding with your bowel movements?
(Current difficulty)
1
2
3
4
5
6
7 (Not a difficulty)
23. How much o f the time during the last two weeks have you felt embarrassed as a result
o f your bowel problem?
(Current difficulty)
1
2
3
4
5
6
7 (Not a difficulty)
24. How much o f the time during the last two weeks have you been troubled by a feeling
o f having to go to the bathroom even though your bowels are empty?
(Current difficulty)
1
2
3
4
5
6
7 (Not a difficulty)
25. How much of the time during the last two weeks have you felt tearful or upset?
(Current difficulty)
1
2
3
4
5
6
7 (Not a difficulty)
26. How much of the time during the last two weeks have you been troubled by
accidental soiling o f your underpants?
(Current difficulty)
1
2
3
4
5
6
7 (Not a difficulty)
27. How much of the time during the last two weeks have you felt angry as a result of
your bowel problem?
(Current difficulty)
1
2
3
4
5
6
7 (Not a difficulty)
28. To what extent has your bowel problem limited sexual activity during the last two
weeks?
(Current difficulty)
1
2
3
4
5
6
7 (Not a difficulty)
29. How much of the time during the last two weeks have you been troubled by feeling
sick to your stomach?
(Current difficulty)
1
2
3
4
5
6
7 (Not a difficulty)
30. How much o f the time during the last two weeks have you felt irritable?
(Current difficulty)
1
2
3
4
5
6
7 (Not a difficulty)
31. How often during the last two weeks have you felt lack o f understanding from others?
(Current difficulty)
1
2
3
4
5
6
7 (Not a difficulty)
32. How satisfied, happy, or pleased have you been with your personal life during the last
two weeks?
(Current difficulty)
1
2
3
4
5
6
7 (Not a difficulty)
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APPENDIX C
CHAPEL HILL INDEX
The following questions relate to problems caused by your Crohn’s disease or ulcerative
colitis. Please answer the questions to the best o f your knowledge. If you cannot
remember exactly, an estimate is fine.
Answer the questions as they relate to your Crohn’s disease or ulcerative colitis, not to
other situations in your life. For example, if your Crohn’s disease was not active, but you
had abdominal pain due to food poisoning, you would circle “None” for Question 2.
1. In the past seven days, how many liquid or very loose stools have you had per day?

2. In the past seven days, how much abdominal pain have you had each day? (Please
circle one o f the following):
None
Mild
Moderate
Severe
3. In the past seven days, how would you rate your general well-being? (Please circle
one o f the following):
Well
Slightly below par
Poor
Very poor
Terrible
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APPENDIX D
MHLC-C

Instructions: Each item below is a belief statement about your medical condition with which you may
agree or disagree. Beside each statement is a scale which ranges from strongly disagree (1) to stron^y
agree (6). For each item we would like you to circle the number that represents the extent to which you
agree or disagree with that statement. ITie more you agree with a statement, the higher will be the
number you circle. The more you disagree with a statement, the lower will be the number you drcle.
Please tnake sure that you answer EVERY ITEM and that you circle ONLY ONE number per item.
This is a measure o f your personal beliefs; obviously, there are no right or wrong answers.
I=STRONCH.Y DISAGREE (SX>)
2=M0DERATELY disagree (MD)
3=SUC»m,Y DISAGREE (D)

4-SUGHTLY AGREE (A )
5HMODERATELY ACHtEE (MA)
6-SniO N G LY AGREE (SA)

;
i|

Is d

2

As to my condition, sWiat will be will be.

4

Most things that afreet my condition happen to me by chance.

1i 1 2

|I am directly responsible for my condition getting better or worse.

l ^
i i
('2 f ï 5 m

Whatever goes wrong with my condition is my own faulL

| 1 C I” f^ 4 ; 5 : 6

#
( 6

m
8

In order for my condidon to improve, h is up to other people to see that
the right things happen.
. 1 1 -j
J2

The main thing which affects my condition is what I myself do.

:i3

_

Following doctor's orders to the letter is the best way to keep my
condition from getting any worse.

14
-,.15
16

i

18

.
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I he ^ e of help I receive from other people determines how soon my
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APPENDIX E
PATIENT KNOWLEDGE QUESTIONNAIRE
The following questions relate to different topics about Crohn’s disease and ulcerative
colitis. Read each statement and circle the response you believe is correct— T if the item
is true, and F if the item is false. If you do not know the answer to an item, please do not
guess; instead, circle DK (don’t know).
1. The following things may be caused by Crohn’s disease or ulcerative colitis:
a. Red eyes.
T
F
b. Dry mouth.
T
F
c. High blood pressure.
T
F
d. Painful joints.
T
F
e. Anemia.
T
F
2. Concerning your bowel:
a. The large bowel connects the outlet o f the stomach to the back passage.
T
F
b. Crohn’s disease affects the small bowel only.
T
F
c. Ulcerative colitis may affect any part o f the bowel.
T
F
d. The small bowel absorbs protein from food into the bloodstream.
T
F
e. The bowel absorbs water from drinks into the bloodstream. T
F

DK
DK
DK
DK
DK

DK
DK
DK
DK
DK

3. The chances o f your children inheriting Crohn’s disease/ulcerative colitis are:
a. Very small.
T
F
DK
b. Greater than if you did not have the disease.
T
F
DK
c. Children o f the same sex as you will probably inherit the disease.
T
F
DK
4. Blood tests are often performed in the colitis clinic for the following purposes:
F
DK
T
a To check your cholesterol level.
DK
F
b. To find out your blood group.
T
DK
T
F
c. To help assess whether your bowel is inflamed.
DK
T
F
d. To check whether you are short of vitamins.
5. Steroid tablets used in treating Crohn’s disease or ulcerative colitis:
a. May build up muscles.
T
b. May cause thinning of bones.
T
c. May cause nosebleeds.
T
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6. When you are well, the following tablets are used in the long-term to prevent
disease/ulcerative colitis from becoming active again;
a. Loperamide (Imodium)
T
F
b. Azathioprine (Azamune, Imuran)
T
F
c. Prednisolone (steroid)
T
F
d. Ranitidine (Zantac)
T
F
e. Sulfasalazine (Salazopyrine)
T
F
f. Mesalazine (Asacol)
T
F

Crohnh
DK
DK
DK
DK
DK
DK

7. Regarding surgical operations in Crohn’s disease and ulcerative colitis:
a. Most people with Crohn’s disease will require an operation at some point during
the course o f their illness.
T
F
DK
b. Most people with ulcerative colitis will require an operation at some point during
the course o f their illness.
T
F
DK
c. Following an operation, Crohn’s disease may occur again elsewhere in the bowel.
T
F
DK
d. Following an operation to remove the large bowel, ulcerative colitis may occur
again elsewhere in the bowel.
T
F
DK
e. Removing part o f the bowel can cause more frequent bowel movements.
T
F
DK
8. Regarding diet in Crohn’s disease and ulcerative colitis:
a. Most people with Crohn’s disease and ulcerative colitis do not need to be
restricted to a low residue (low fiber) diet.
T
F
b. You should avoid sugary foods.
T
F
c. You need not restrict your alcohol intake because you have Crohn’s
disease/ulcerative colitis.
T
F
d. You should avoid milk.
T
F
9. If you should start with an episode o f diarrhea you should:
a. Continue to eat as you normally would.
T
F
b. Wait a while but see your doctor if it persists for more than three weeks.
T
F

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

DK
DK
DK
DK
DK
DK

99
APPENDIX F
SOCIAL SUPPORT QUESTIONNAIRE (SHORT FORM)
SSQ6
The following questions ask about people in your environment who provide you with
help or support. Each question has two parts. For the first part, list all o f the people
that you know, excluding yourself, whom you can count on for help or support in the
manner described. Give the persons’ initials and their relationship to you (see
example). Do not list more than one person next to each o f the numbers beneath the
question.
For the second part, circle how satisfied you are with the overall support you have. If
you have had no support for a question, check the words “No one,” but still rate your
level o f satisfaction. Do not list more than nine persons per question.
Please answer all o f the questions as best as you can. All o f your responses will be
kept confidential.
EXAMPLE;
Who do you know whom you can trust with information that could get you in
trouble?
No one

1) T.N. (brother)
2) L.M. (friend)
3) R S . (friend)

4) T.N. (father)
5) L.M. (employer)
6)

7)
8)
9)

How satisfied?
6-very
satisfied

5-fairly
satisfied

4-a little
satisfied

3-a little
dissatisfied

2-fairly
dissatisfied

1-very
dissatisfied

1. Whom can you really count on to be dependable when you need help?
No one

1)
2)

4)
5)

3)

6)

7)
8)
9)

2. How satisfied?
6-very
satisfied

5-fairly
satisfied

4-a little
satisfied

3-a little
dissatisfied

2-fairly
dissatisfied

1-very
dissatisfied
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3. Whom can you really count on to help you feel more relaxed when you are under
pressure or tense?
No one

4)
5)
6)

1)
2)
3)

7)
8)
9)

4. How satisfied?
6-very
satisfied

5-fairly
satisfied

4-a little
satisfied

3-a little
dissatisfied

2-fairly
dissatisfied

1-very
dissatisfied

5. Who accepts you totally, including your worst and your best points?
No one

1)
2)
3)

4)
5)
6)

7)
8)
9)

6. How satisfied?
6-very
satisfied

5-fairly
satisfied

4-a little
satisfied

3-a little
dissatisfied

2-fairly
dissatisfied

1-very
dissatisfied

7. Whom can you really count on to care about you, regardless o f what is happening
to you?
No one

1)
2)
3)

4)
5)
6)

7)
8)
9)

8. How satisfied?
6-very
satisfied

5-fairly
satisfied

4-a little
satisfied

3-a little
dissatisfied

2-fairly
dissatisfied

1-very
dissatisfied

9. Whom can you really count on to help you feel better when you are feeling
generally down-in-the-dumps?
No one

1)
2)
3)

4)
5)
6)

7)
8)
9)
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10. How satisfied?
6-very
satisfied

5-fairly
satisfied

4-a little
satisfied

3-a little
dissatisfied

2-fairly
dissatisfied

1-very
dissatisfied

11. Whom can you count on to console you when you are very upset?
No one

1)
2)
3)

4)
5)
6)

7)
8)
9)

12 How satisfied?
6-very
satisfied

5-fairly
satisfied

4-a little
satisfied

3-a little
dissatisfied

2-fairly
dissatisfied

1-very
dissatisfied
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APPENDIX G
Institutional Review Board Proposal
The Relationship of Health Beliefs, Knowledge o f Disease, and Social Support to HealthRelated Quality o f Life in Patients with Inflammatoiy Bowel Disease
Principal Investigator: Michael T. Bach
Under the direction of D. Balfour Jeffrey, Ph.D.
1. Purpose of the Research Project
The purpose o f this study is to examine the relationship o f several factors—health
beliefs, patient knowledge, and satisfaction with social support—to health-related quality
o f life in patients with inflammatory bowel disease (IBD) Despite the attention given to
pharmaceutical and surgical treatments o f the physical symptoms o f IBD, less research
has been devoted to studying the other areas that this illness effects, such as emotional
and social functioning (areas subsumed under the heading, health-related quality of life).
The major hypothesis o f this study is that the above factors will predict health-related
quality o f life better than will disease activity alone. If this prediction occurs,
interventions based on this finding will be discussed. These include increasing a person’s
belief in his or her ability to effect positive health outcomes, providing information about
IBD to interested patients, and providing interested people with listings of local IBD
support groups.
2. The Subjects
The subjects will be 100-150 persons from Michigan who are 18 or older and who
have a diagnosis o f inflammatory bowel disease.
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3. Recruiting or Selecting Subjects
Potential subjects will have the study briefly explained to them by a
gastroenterologist from Michigan during a regularly scheduled appointment. Those who
wish to participate will be given a packet containing questionnaires measuring the above
constructs.
4. Where the Study Will Take Place
Subjects will complete the questionnaires at their homes in Michigan. The
information gathered from the questionnaires will then be analyzed in Montana.
5. The Activities the Subjects Will Perform
The subjects will complete five questionnaires: a Demographic Questionnaire
(Appendix A) that asks about gender, age, and type o f disease; the Inflammatory Bowel
Disease Questionnaire (Appendix B), which will measure health-related quality o f life;
the Chapel Hill Index (Appendix C), which will measure disease activity; the
Multidimensional Health Locus o f Control Scale, Form C (Appendix D), which will
measure a person’s beliefs about how his or her behavior affects health outcomes; the
Patient Knowledge Questionnaire (Appendix E), which will assess a patient’s knowledge
about IBD; and the six-item Social Support Questionnaire (Appendix F), which will
measure a patient’s satisfaction with the social support he or she is receiving. These
questionnaires are brief, with a total completion time o f approximately one hour When
the subject have completed the questionnaires, they will place them in a stamped
envelope with prepaid postage that is addressed to the principal investigator.
6. Benefits of the Research
If the predicted results occur, several possible interventions designed to improve the
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health-related quality o f life o f IBD patients become promising. These include increasing
a person’s belief in his or her ability to effect positive health outcomes, providing
information about IBD to interested patients, and providing interested people with listings
o f local IBD support groups.
7. Risks and Discomforts to Subjects
The potential risks and discomforts to the subjects in this study are minimal because
they will fill out the questionnaires only once, and will need only one hour to complete
them. Although some o f the questions that they will respond to require revealing slightly
embarrassing information (such as the frequency o f bowel movements in the past two
weeks), none o f the forms ask for the person’s name. In fact, the Subject Instructions
(see Appendix H) explicitly state that subjects are not to put their names on any o f the
questionnaires.
8. Minimizing Deleterious Effects
Questionnaire packets will be distributed only to those subjects who express an
interest in the study. Those who do not wish to participate will not be pressured in any
way to do so. Once at home, subjects can choose not to complete the forms if they find
them objectionable for any reason. For such subjects, no negative consequences will
follow, because the gastroenterologist will not follow-up on their agreement to
participate.
9. How the Subject’s Privacy is to be Protected
Instead o f requiring subjects to write their names, each questionnaire in a packet will
have an identification number on it. This will eliminate the possibility o f personal
information being attached to any o f the subjects.
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10. Request for a Waiver of the Written Consent Form
Because o f the sensitive nature o f some o f the information gathered, it is essential
to preserve the anonymity o f the participants in this study. For this reason, a waiver of
informed consent is requested, as it will ensure total anonymity for the participants. In
lieu o f a consent form, participants are told in the instructions that mailing back the
questionnaires is tantamount to giving their consent to participate in this study. In
addition, every effort has been made to state the voluntary nature o f their participation.
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APPENDIX H
PARTICIPANT INSTRUCTIONS
Thank you very much for agreeing to participate in this study. I am interested in
how certain factors influence health-related quality o f life (HRQOL) in persons like both
you and myself, who suffer from inflammatory bowel disease (IBD) I was diagnosed
with Crohn's disease about six years ago, and was a patient o f Dr. Noren’s when I lived
in Marquette. As you know, having IBD affects many areas o f your life in addition to
physical comfort, like your emotions and your ability to enjoy social activities. These
areas that are impacted by IBD affect your current satisfaction with life, or HRQOL.
The questionnaires in this packet are designed to measure disease activity (of
either Crohn’s disease or ulcerative colitis), HRQOL, beliefs about how your behavior
influences your condition, your knowledge about IBD, and your satisfaction with the
social support that you are receiving. Hopefully, this study will provide ideas for
increasing HRQOL in the areas mentioned above. Your participation will help make this
possible.
Please fill out the questionnaires carefully after reading the instructions on each of
them, but do not put your name on any o f the forms. By not putting your name on the
forms you can be assured that the information you record will be kept absolutely
anonymous. If you have any questions while completing these measurements, feel free to
call me at (406) 243-4523. If you find that filling out these questionnaires is
burdensome, you may dispose of them. I hope, however, that you will complete them,
because your participation will add to our knowledge about how to improve the treatment
o f IBD. This project should take only about an hour o f your time. Please try to finish
these as soon as possible and, when you are done, simply seal them up and drop the
envelope in the mail. Because you will not be signing your name to any of the forms, by
mailing back the questionnaires you are giving your consent to participate in this study.
If you would like to know more about this research, feel free to call, e-mail, or
write me at the numbers below; I would be glad to answer any questions. I would also be
happy to send you a summary o f the results when the study is finished. Thanks so much
for your time, and I wish you well.
Sincerely,
Michael Bach
Professor D. Balfour Jeffrey, Ph.D.
Study Supervisor
For more information contact:
Michael Bach
Clinical Psychology Center
1444 Mansfield Avenue
Missoula, MT 59812
e-mail: mbach@.bigskv net
(406) 243-4523
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APPENDIX I
IBDQ ITEMS ACCORDING TO SUBSCALE
Bowel Subscale
How frequent have your bowel movements been during the last two weeks?
How much o f your time during the last two weeks have your bowel movements
been loose?
How often during the last two weeks have you been troubled by cramps in your
abdomen?
How often during the last two weeks have you been troubled by pain in the
abdomen?
Overall, in the last two weeks, how much of a problem have you had with passing
large amounts o f gas?
How much o f the time during the last two weeks have you been troubled by a
feeling o f abdominal bloating?
How much o f the time during the last two weeks have you had a problem with
rectal bleeding with your bowel movements?
How much o f the time during the last two weeks have you been troubled by a
feeling o f having to go to the bathroom even though your bowels are empty?
How much o f the time during the last two weeks have you been troubled by
accidental soiling o f your underpants?
How much o f the time during the last two weeks have you been troubled by
feeling sick to your stomach?
Svstemic Subscale
How often has the feeling o f fatigue or o f being tired and worn out been a
problem for you during the last two weeks?
How much energy have you had during the last two weeks?
How often during the last two weeks have you felt generally unwell?
How often during the last two weeks have you had problems getting a good
night’s sleep, or been troubled by waking up during the night?
Overall, in the last two weeks, how much o f a problem have you had maintaining,
or getting to, the weight you would like to be at?
Emotion Subscale
How often during the last two weeks have you felt frustrated, impatient, or
restless?
How often during the last two weeks did you feel worried about the possibility of
needing to have surgery because o f your bowel problem?
How often during the last two weeks have you been troubled because o f fear of
not finding a washroom?
How often during the last two weeks have you felt depressed or discouraged?
Many patients with bowel problems often have worries and anxieties related to
their illness. These include worries about getting cancer, worries about never feeling any
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better, and worries about having a relapse. In general, how often during the last two
weeks have you felt worried or anxious?
How often during the last two weeks have you felt relaxed and free o f tension?
How much of the time during the last two weeks have you felt embarrassed as a
result o f your bowel problem?
How much o f the time during the last two weeks have you felt tearful or upset?
How much o f the time during the last two weeks have you felt angry as a result of
your bowel problem?
How much o f the time during the last two weeks have you felt irritable?
How often during the last two weeks have you felt lack o f understanding from
others?
How satisfied, happy, or pleased have you been with your personal life during the
last two weeks?
Social Subscale
How often during the last two weeks have you been unable to attend school or
work because o f your bowel problem?
How often during the last two weeks have you had to delay or cancel a social
engagement because o f your bowel problem?
How much difficulty have you had, as a result o f your bowel problems, doing
leisure or sports activities you would have liked to have done during the last two weeks?
How often during the last two weeks have you had to avoid attending events
where there was no washroom close at hand?
To what extent has your bowel problem limited sexual activity during the last two
weeks?
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APPENDIX J
MEANS AND STANDARD DEVIATIONS FOR SCALES IN THE CROHN’S
DISEASE AND ULCERATIVE COLITIS GROUPS

Crohn’s disease*

Ulcerative colitis**

Instrument
cm
MHLC
KQ
SSQ-6
IBDQ Bowel
IBDQ Systemic
IBDQ Emotion
IBDQ Social
IBDQ Total

Mean
211.8
20.4
18.5
5.1
46.9
19.7
52.7
25.6
144.9

Mean
125.7
19.8
20.3
5.4
54.5
24.0
64.1
29.6
172.2

SD
127.7
7.0
5.2
.9
12.2
7.2
12.9
7.2
36.6

Age
Length o f illness

44.6
14.0

48.1
16.9

15.5
14.6

SD
125.8
6.7
6.1
1.3
11.5
7.4
16.9
8.1
40.3
17.4
11.6

* n = 45; ** n = 17
CHI = Chapel Hill Index (higher scores = more severe symptoms); MHLC =
Multidimensional Health Locus o f Control-Internal; KQ = Knowledge Questionnaire;
SSQ-6 = Social Support Questionnaire (Satisfaction Scale); IBDQ = Inflammatory Bowel
Disease Questionnaire (higher scores = improved HRQOL)

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

110

APPENDIX K
ANNOUNCEMENT OF STUDY IN IBD NEWSLETTER

A Study of Hecdth^’Related Q^aUty of Life
in Patients w ith Crohn*s Dweose ;
, or Ulcerative Colitis
-t
Greetings allt My name is Mike Bach,
I am currendy
working on my Master's thesis at the University of Montena
with my supervisor, Balfour Jeffrey, Ph.D. I am asking r efer s to
consider participating in this study ofhovv œrtain factors are
related to health-related quality of life in Crohn's disease and '
ulcerative colitis. A lot of fantastic research is currendy aimed at
treating the physical symptoms of inflammatory bowel disease
(IBD). I am interested, however, in how health beliefs, knowl
edge about IBD, and satisfaction with social support are related
to living with this illness. You can help shed light on these
relationships by tilling out an anonymous questionnaire packet
that can be completed in less than 45 minutes. If you have IBD,
are 18 years of age or older, and do not have an ostomy bag,
please consider e-mailing or sending me an address where you
can receive the questionnaire packet It will contain instructions
and a postage-paid return envelope. Remember, your responses
are TOTALLY ANONYMOUS. Your time can help provide ideas
to help people who—like both you and myself-^ive each day
with IBD. I plan to finish this study this fall and will write a
summary of results from the quesionnaires I receive. The
Northwest Chapter of the CCFA will publish that summary in
the Winter 2001 newsletter. Thanks for your help!!!
Mike Bach, O inical Psychology Center
1444 M ansfield Avenue, Missoula, MT 59812
e-mail: m bach@ bigsky.net

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

